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ABSTRACT

The interaction of hyperinsulinemia, the sympathetic nervous system
(SNS) and nitric oxide (NO) was examined in lean and obese unilaterally
lumbar sympathectomized dogs. Six lean and six obese dogs were studied
while on a treadmill, during hyperinsulinémie euglycemic clamp (HIEC)
procedures w ith and without concurrent nitric oxide synthase (NOS)
inhibition w ith nitro-L-arginine (LNA). Changes in plasm a insulin, femoral
vascular resistance (FVR), h eart rate (HR) and mean arterial pressure
(MAP) were measured prior to and during a 7-week overfeeding period, and
response to LNA administration was examined in the lean and obese state.
Body weight increased from 19.9 ± 0.70 to 29.7 ± 0.77kg and % body
fat from 23.0% to 48.8% during overfeeding (OF). H eart rate, MAP and
plasma insulin also increased during overfeeding. Femoral vascular
resistance initially increased (p<0.01 in both the intact and denervated
limbs), but returned to baseline levels by OF-week 3 in the denervated limb,
and by week 6 in the intact limb. No significant correlation w as evident
between insulin levels and other cardiovascular param eters.
Hyperinsulinémie euglycemia alone did not affect MAP in either
weight group. However, when hyperinsulinemia was initiated following
NOS inhibition, MAP in the lean animals tended to decrease, whereas th a t
of the obese dogs increased slightly. HR response to hyperinsulinemia
(alone or concurrent w ith NOS inhibition) was not different between weight
groups. The FVR response to hyperinsulinemia alone or w ith NOS
ix
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inhibition was not different between the weight groups. However, heart
rate and vascular response to LNA was reduced in the obese dog.
In summary, sympathetic activity may influence the vascular
response to weight gain. Also, hyperinsulinem ia does not affect MAP, HR or
FVR in lean or obese dogs, while walking slowly on a treadm ill. However,
w hen NOS is concurrently inhibited, lean and obese dogs show a tendency
tow ard differential MAP and HR responses to hyperinsulinemia. Thus, the
insulin and nitric oxide interaction may differ in lean and obese dogs, and
may mediate development of hypertension in the obese population. Finally,
the obese have a reduced cardiovascular response to NOS inhibition
compared to the lean.
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C H A PTER 1: IN T R O D U C T IO N

Obesity-induced hypertension is a significant clinical health risk.
Approximately 25% - 50% of hypertensive people are obese (Hseuh and
Buchanan, 1994), w ith the majority dem onstrating significant reduction in
blood pressure following weight loss (e.g., Weinsier et al., 1991). However,
the exact mechanism by which obesity-induced hypertension develops has
not been fully elucidated. In recent years, studies exam ining the
mechanisms through which hypertension develops w ith obesity have
concentrated on the role of hyperinsulinem ia and insulin resistance (For
reviews see Modan and Halkin, 1991; H all et al., 1994; Landsberg, 1991).
Both obese and non-obese hypertensive individuals are in sulin resistant
(Ferrannini et al., 1987), w ith significant correlation observed between
circulating insulin levels and blood pressure. Despite these data, more
recent studies report th a t hyperinsulinem ia alone does not elevate blood
pressure in either normal or insulin resistan t dogs (Brands et al., 1991; Hall
et al., 1990 & 1995). However, hyperinsulinem ia does elevate arterial
pressure in the ra t (Meehan et al., 1994), and activation of the sympathetic
nervous system (SNS) may be one mechanism through which insulin may
promote elevations in arterial pressure (Daly and Landsberg, 1991). Thus,
controversy rem ains as to the involvement of in sulin/in sulin resistance in
obesity-induced hypertension.
There is a growing body of evidence th a t the obese state results in an
altered p attern of sympathetic activity. Increased norepinephrine levels
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have been observed in overweight hypertensive individuals (Rocchini et al.,
1989), which could potentially mediate elevations in arterial pressure
through increases in peripheral resistance and/or altered renal function
precipitating fluid and sodium retention (DiBona, 1992). Acute elevations
in insulin stimulate sympathetic activity in several species (Young et al.
1988; Liang et al., 1982; Rowe et al., 1981), and may be one mechanism
through which elevations in arterial pressure occur (Daly and Landsberg,
1991). Still, others have shown vasodilation in skeletal muscle by insulin
(for review see Baron, 1994). However, in insulin resistant subjects (e.g.
obese), this response is reduced (Laakso et al., 1990). In addition, the
response to vasoconstricting agents is enhanced in insulin resistant rats
(Townsend et al., 1992). Thus, the obese insulin resistant state could
predispose to changes in vascular resistance consistent w ith elevations in
arterial pressure through alterations in SNS activity. Recent evidence
suggests th at altered sym pathetic activity is essential for the development
of obesity-related hypertension, via renal mechanisms (Kassab et al., 1994).
However, the exact role sympathetic activity plays in the development and
maintenance of obesity-induced hypertension remains obscure.
Another factor which may play a crucial role in the etiology of
obesity-associated hypertension is nitric oxide. Nitric oxide (NO) has come
under much scrutiny for its abihty to cause vascular relaxation and
reductions in peripheral resistance. It is also a potential modulator of
nervous, renal and immune system function. Initial studies suggest th a t

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

the nitric oxide system may be im portant in various organ system s for
normal physiologic functioning as well as in some disease states.
Since acute and chronic NO inhibition results in increased arterial
pressure in several species, the role of NO as a possible m ediator of
cardiovascular hemodynamics and vascular responses in various models of
hypertension has received much examination (Panza et al., 1993; Lockette
et al., 1986; Roller et al., 1994). In 1990, Panza et al. described abnormal
vascular relaxation in patients w ith essential hypertension, w hich was later
found to be, a t least in part, due to a defect in the NO system (Panza et al.,
1993a, b). A potential role for the nitric oxide system in nervous tissue
function has been explored. Studies suggest th at in addition to modulating
vascular resistance through peripheral mechanisms, NO m ay play a role in
central regulation of sympathetic tone and/or renal nerve activity, while
other experiments suggest th a t sympathetic activation is a m odulator of NO
release (LacoUey et al., 1991).
In addition to interactions with the nervous system, nitric oxide
activity has also been studied w ith regard to its actions on in sulin release,
activity and sensitivity. Recent studies report th at the vasodilating effects
of insulin are mediated through the stimulation or synthesis/release of
nitric oxide. (Scherrer et al., 1994, Steinberg et al., 1994). There is a
suggestion in the literature th a t a positive relationship exists between
endothelial nitric oxide production and in sulin sensitivity (Petrie et
al., 1996). This finding is supported in the study by Higashi, e t al. 1997, in
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which th e increase in ren al plasma flow, the decrease in renal vascular
resistance and filtration firaction and the increase in cGMP in response to
arginine infusion was reduced in essential hypertensive subjects. Also,
these insulin resistant individuals showed a higher insulin response to Larginine infusion compared to their normotensive, insulin sensitive
counterparts. Thus, a relationship exists between in sulin, in sulin
sensitivity and endothehal nitric oxide, and defects in any aspect of this
system could be a potential mediator of hypertension observed in insulin
resistan t states such as obesity. However, these interactions have yet to be
described in the obese.
Thus, our objectives were to examine the interaction between in sulin,
the SNS and nitric oxide in mediating femoral blood flow and vascular
resistance in conscious lean and obese dogs. Also, since httle inform ation on
the tim e course of vascular resistance changes and the onset of in sulin
resistance occurring w ith obesity is currently available in the literature, we
followed these param eters over seven weeks of overfeeding and weight gain.
To study the interaction of insulin and sym pathetic activity in
m ediating vascular resistance in the lean state and w ith the development of
obesity, the hyperinsulinémie euglycemic clamp (HIEC) technique was
utilized in lean and obese dogs with unilateral lum bar sympathetic
denervation. To determ ine whether the nitric oxide system is also involved
in the development of obesity-related hypertension through either
interactions with the SNS and/or insulin, we examined the effects of nitric
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oxide synthase inhibition on the cardiovascular responses during the HIEC
in the sam e lean and obese dogs. Last, we examined w hether changes in
vascular resistance and hyperinsulinemia develop concurrently during the
course of the development of diet-induced obesity, and w hether the vascular
changes were affected by sympathetic innervation. To procure these data,
weekly standing and walking femoral blood flow and fasting insulin and
glucose levels were monitored over the course of development of obesity in
lum bar sympathectomized dogs. Thus, the time course for development of
vascular resistance changes, hyperinsulinemia, and correlation between the
two param eters could be determined.
We hypothesize th a t as insulin resistance develops w ith weight gain,
insulin’s effect to reduce vascular resistance is decreased. A t this time,
increases in SNS activity associated with obesity alter peripheral vascular
resistance, laying a foundation for hypertension to develop. We also
hypothesize th at the increase in SNS activity which develops w ith weight
gain inhibit the activity of vascular nitric oxide synthase (NOS), thereby
predisposing to hypertension in the obese. Additionally, this reduction in
nitric oxide activity m ay influence cardiovascular responses to insulin and
influence arterial pressure, since there is suggestion in the h te ra tu re that
nitric oxide may m ediate the vascular effects of insulin (Steinberg et al.,
1994, Scherrer et al., 1994).
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CH APTER 2: R EV IEW O F LITER A TU R E

Along with atherosclerotic vascular disease and certain cancers, the
risk of hypertension is increased w ith obesity (Kannel et al., 1967). In
addition, obesity is reported as an independent predictor of stroke,
cardiovascular death, coronary artery disease and congestive h ea rt failure
(Hubert et al., 1983). Hypertension itself is a major risk factor for coronary
heart disease, stroke and congestive heart failure (Kannel et al., 1972 and
1976; Pooling Project, 1978). Thus, obesity-induced hypertension is a
significant clinical health risk afOicting humans.
Approximately 25% - 50% of obese individuals are hypertensive
(Hseuh and Buchanan, 1994), w ith the majority demonstrating significant
reduction in blood pressure following weight loss (for example, W einsier et
al., 1991). Although the exact mechanisms by which hypertension develops
in the obese remain obscure, increases in cardiac output and blood volume,
insulin resistance and renal sodium retention are reported to occur
concurrent with weight gain and the development of hypertension in both
hum ans and the canine model (Alexander et al., 1962; Mujais et al., 1982;
Rocchini et al., 1987 and 1989a, b, c). Also, the acute response to sodium
loading, the pressor response to angiotensin H, an d catecholamine levels are
altered in obese hypertensive hum an patients an d in a n im al models
(Rocchini et al., 1989a, b, c and 1990; West et al., 1991; Rowe et al., 1981;
Tuck et al., 1992).
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For many years, studies examining the mechanism s of obesity related
hypertension concentrated on the role of hyperinsulinemia and insulin
resistance (For review see Modan et al., 1991; Hall et al., 1994; Landsberg,
1986). Both obese and non-obese hypertensives are insulin resistant
(Ferrannini et al., 1987), w ith significant correlation between circulating
in sulin levels and blood pressure. In addition, strong correlation has been

identified between hypertension and insulin resistance in several disorders
(non-insulin dependent diabetes meUitus [NIDDM], obesity), and insulin

infusion in rats elevates arterial pressure (Qadir et al., 1996). Thus,
hyperinsulinemia and insulin resistance were hypothesized to be primary
factors in the development of hypertension in the obese, through either
direct effects on renal Na+ absorption or via insulin-induced activation of
the sympathetic nervous system (SNS) w ith resultant changes in vascular
resistance and/or renal sodium handling. However, a growing body of
evidence suggests th a t the obese state results in an altered p attern of
sympathetic activity to peripheral resistance vessels and the kidneys, which
is essential for the development of obesity-related hypertension (Kassab et
al., 1994). Still, the specific mechanisms through which hypertension
develops w ith weight gain rem ain obscure, and investigators now are
considering the involvement of the nitric oxide system as an additional piece
to the insulin and hypertension puzzle.
Over the time course of research into the cause of obesity-induced
hypertension, the hyperinsulinem ia and insulin resistance associated w ith
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this disorder has received a vast am ount of interest. This in terest w as
sparked by observations th a t insulin resistance and glucose intolerance
were correlated w ith the development of hypertension in both obese and
non-obese subjects (Bonora et al., 1987; Lucas et al., 1985; M odan et al.,
1985; Ferannini et al., 1987; M anicardi et al., 1986; Rocchini et al, 1987 and
1989a). In 1986, Lewis Landsberg published a schematic of direct and
indirect mechanisms through which hyperinsuhnemia/insulin resistance
could potentially resu lt in hypertension with obesity (Figure 1).
In short, w ith w eight gain, insulin levels increase during the
development of insulin resistance (primarily skeletal muscle insulin
resistance). As this occurs, elevated in sulin stimulates the SNS resulting in
increases in peripheral and/or renal vascular resistance and h e a rt rate,
predisposing to hypertension. Along w ith these changes, the increase in
insulin could directly alter renal sodium handling, thereby alterin g whole

body fluid balance and potentiating increases in blood pressure. Thus, in
this model, there are several mechanisms w arranting experim entation to
decipher the pathway(s) responsible for the elevation in arterial pressure
associated with weight gain. However, all revolve around
hyperinsulinem ia/insulin resistance as the primary/inciting factor.
Contradictory to this hypothesis, insulin has been shown to produce
vasodilatation in skeletal muscle vasculature, with associated increases in
blood flow (For review see Baron, 1994). This, intuitively, should ten d to
reduce MAP. However, in obesity this response is impaired (Laakso et al..
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Figure 1: Summary of mechanisms possibly resulting in obesity-related
hypertension. Copied w ith sbght modification from Landsberg, 1986.
1990). In 1993, Feldman and Bierbrier reported decreasing vascular
sensitivity to insulin w ith increasing body mass in men. Also, the potency
of i n s u lin as a venodilator was reduced 79% in the mildly hypertensive
subjects of this study. In addition to the above f in d in g s, the vascular
response to vasoconstrictive agents has been shown to be enhanced in
insulin resistant rats (Townsend et al., 1992). Thus, although in s u lin has
been shown to increase blood flow and reduce vascular resistance, changes
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10
in tissue response to insulin in obesity, in conjunction with, altered
sympathetic activity, could mediate the development of obesity-induced
hypertension. In addition, the influence of insulin and the SNS in the
control of peripheral vascular resistance or renal function may vary over the
time course of the development of obesity-induced hypertension (Kraegen et
al., 1991; Penicaud et al., 1987). Insulin sensitivity of th e kidneys and
skeletal muscle changes during the development of obesity. Thus, as
insulin resistance develops in the vasculature and kidneys, sympathetic
activity may become the primary factor mediating increased peripheral
vascular resistance and/or renal sodium retention during the
development/maintenance of obesity.
In studies to further describe mechanisms through which insulin may
influence arterial pressure, the sodium r e t a in in g effects of in s u lin have been
clearly demonstrated in vitro using isolated dog kidneys (Baum et al., 1987;
Nizet et al., 1971) and renal micropuncture techniques (DeFronzo et al.,
1976). These studies suggest th at in s u lin has direct effects in vitro to
promote sodium reabsorption across the thick loop of th e ascending limb of
Henle and the proximal and distal renal tubules. In vivo, these effects could
predispose to the development of hypertension in the obese, as obesity is an
insulin resistant/hyperinsulinemic and volume-expanded state, w ith
increased cardiac output and sodium retention (Rocchini et al., 1987 and
1989a, b, c). Although these vascular and renal effects of in s u lin may be
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11
im portant factors involved in the development of hypertension in the obese,
Hall and colleagues (1990, 1991 and 1995; Brands et al., 1991) have shown
th a t hyperinsulinemia alone does not result in elevated blood pressure in
the dog. Thus, the development of in s u lin resistance and interactions w ith
other systems such as the SNS or nitric oxide are likely to be im portant
factors which mediate the development of obesity-induced hypertension.
The development of insulin resistance in different tissues such as the
kidney, liver and skeletal muscle is thought to occur at different rates
(Kraegen et al., 1991; Penicaud et al., 1987). Hence, the physiologic
responses of these tissues, and their relationship to circulatory/arterial
pressure control, may vary over the course of the development of
hypertension in the obese.
Recent evidence in the obesity-induced hypertensive dog model
suggests th a t renal innervation is a prim ary mechanism required for the
development of hypertension (Kassab et al., 1994). In this study, renal
denervation attenuated the development of increased arterial pressure with
the development of obesity. Another study by this same group (Kassab et
al., 1995) suggests th a t the renal sympathetic activity may be im portant
during the development of obesity-induced hypertension, since b asal urine
sodium excretion of innervated kidneys of obese dogs was significantly
lower th a n th at of the lean control animals. This difference w as abolished
using bilateral renal denervation in the obese dogs, but denervation had no
effect on basal urinary sodium excretion in the lean controls. These data

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

12
support the idea th a t renal sympathetic activity m ay be activated and
responsible, in part, for the development of obesity-associated hypertension.
However, increases in sympathetic activity could also predispose to
increased arterial pressure in the obese patient th ro u g h alterations in
peripheral vascular resistance (DiBona, 1992). Insulin has been shown to
have multiple effects on the sympathetic and cardiovascular systems th a t
could potentially result in hypertension. Thus, the interaction of insulin
and these systems should be considered in the etiology of obesity-related
hypertension.
For years the sympathetic nervous system has been suggested as a
possible mechanism for hypertension. Increased SNS activity is reported to
occur in obesity-related hypertension, as increased circulating
norepinephrine levels have been observed (Rocchini e t al., 1989a, b, c).
Increased SNS activity may mediate elevations in a rte ria l pressure in the
obese through either increases in peripheral vascular resistance or ren al
mechanisms (DiBona, 1992). Changes in sym pathetic activity may be an
integral mechanism through which hypertension develops w ith obesity,
since Kassab et al. (1994) provided evidence th a t re n a l innervation is
crucial for the development of hypertension in diet-induced obesity in th e
canine model. Investigation into the interaction of in su lin and sym pathetic
activity as a mechanism for hypertension has been fueled by the finding
th a t insulin infusion causes increased heart rate an d cardiac output, an d
elevations in circulating norepinephrine (Viberti et al., 1981; Rowe et al..

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

13
1981). Studies such as these lay groundwork for the thought th a t
hyperinsulineinia in insulin resistant obese patients may stim ulate SNS
activity, which m ay then increase vascular resistance or reduce renal
sodium and w ater excretion, predisposing to hypertension (Figure 1).
Numerous studies using the hyperinsulinémie euglycemic clamp in rats
(Young, 1988), dogs (Liang et al., 1982) an d hum ans (Rowe et al., 1981)
demonstrate th a t acute elevations of insulin will stim ulate sympathetic
activity. Assessment of circulating norepinephrine levels, changes in
regional blood flow, or direct nerve recordings were examined as measures
of SNS activity. In a recent study using microelectrode nerve recordings
during euglycemic hyperinsulinemia, muscle sympathetic nerve activity
increased significantly during insulin infusion a t both norm al and supraphysiologic insulin levels (Berne, et al., 1992). In this study,
hyperinsulinemia was associated with increased vasoconstrictor nerve
activity to skeletal muscle, b u t blood pressure was not notably affected.
This suggests a direct stimulatory effect of hyperinsulinemia on vascular
sympathetic activity, without a significant associated arterial pressure
increase. Another recent study dem onstrated th a t sym pathetic nerve
hyperactivity precedes the appearance of hyperinsulinem ia an d MAP
elevations in a non-obese population (Masuo, 1997). Thus, the mechanisms
through which hypertension is mediated, and how they are altered in
insulin resistant and/or hypertensive states such as obesity, m ay be closely
related to sympathetic activity. The importance of SNS activity in
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hypertension is gaining more support, as a recent study in hum ans
(Facchini, 1996) reported th a t increased h eart rate and insulin resistance
are highly correlated in humans, and this increase in h eart rate
presum ably reflecting increased cardiac output) is consistent w ith insuhninduced increases in sympathetic activity. However, other studies have
previously reported th at the increase in h eart rate observed with obesity is
the result of a reduction in parasym pathetic nervous system activity
controlling heart rate (Truett et al., 1996; Kirsch et al., 1991). Using
microneurography, Anderson et al. (1991 and 1992), reported th a t
physiologic increases in plasma insulin elevate sympathetic outflow in
healthy and borderline hypertensives, but produce vasodilation and do not
elevate blood pressure. Lembo et al., (1992) reported sim ilar basal glucose
uptake in normal and hypertensive subjects, with considerable increases in
glucose uptake in response to insulin. However, the glucose uptake levels
attained in the hypertensive group were significantly lower than those of
the controls. During the hyperinsulinémie period of these studies, forearm
norepinephrine (NE) release increased by 35% in normotensive patients.
This was considerably greater in the hypertensive group, who exhibited a
140% increase in NE release. Nevertheless, the mechanism by which
in sulin induces muscle sympathetic overactivity is not yet completely

understood. Suggested hypotheses include action on the central nervous
system (CNS: ventromedial hypothalamic neurons), an indirect baroreflexmediated action and a direct effect on muscle (for review, see Lembo e t al..
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1996). The majority of data suggests th a t the effect of insulin on muscle NE
is mediated through either central mechanisms or peripheral reflexes
(Lembo et al, 1996 for review). However, one m ust consider th a t the clamp
procedure itself, with only saline infusion, is reported to increase
norepinephrine levels without elevating blood pressure (Moan et al., 1995).
This questions w hether changes in SNS activity described in previous clamp
studies were a result of the experimental procedure, or insulin, per se. This
requires further study. Regardless, the studies mentioned suggest th a t
alterations in autonomic/sympathetic activity which occur in obesity may be
a more im portant m ediator of hypertension in the obese th a n originally
implied, and the mechanism may involve interaction with insulin. Also,
these pathw ays may involve interaction w ith other vasoactive factors such
as nitric oxide, as one study reports th at insulin-induced vasodilatory
responses are not m ediated by beta-adrenergic or cholinergic mechanisms,
and are not markedly affected by alpha-adrenergic mediated mechanisms
(Randin et al., 1994).
Although much study has examined the influence of in sulin on
sympathetic activity, the sympathetic nervous system has also been
explored as a possible modulator of insulin-induced glucose uptake. This
question is much more difficxdt to explore, since norepinephrine (NE) is a
neurotransm itter, and circulating levels only poorly reflect synaptic cleft
concentrations (Lembo, 1992). The idea th a t NE may potentially alter
insulin action is suggested by the observation th a t in various models of
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complete sympathectomy, the normalization of glucose &om insulin-induced
hypoglycemia is im paired (Sacca et al., 1977; Schacter et al., 1951;
McDonough, 1939). This does not occur with reduced epinephrine levels,
suggesting a metabolic role for NE (Gerich et al., 1979). In 1994, Lembo
and colleagues directly tested w hether NE release w as able to provoke an
im pairm ent in in s u lin sensitivity m easured using the in s u lin euglycemic
clamp technique. They observed th a t when insulin was infused during
lower body negative pressure (LBNP; a technique used to stim ulate
baroreflex activation of NE release by applying negative pressure to the
body below the iliac crest using a pressurized airtig h t chamber) the
increm ent in forearm NE release was greater th a n in control LBNP studies
(Lembo et al., 1994a). Also, forearm glucose uptake was activated during
in s u lin infusion in control and LBNP patients, but the values obtained

during LBNP were 40% lower th an during the control study. A dditional
data supporting these observations has been presented by others (Jam erson
et al., 1993 and 1994). Possible mechanisms by which LBNP im pairs
in s u lin action on muscle glucose uptake are either via hemodynamic

mechanisms leading to reduced perfusion or through direct metaboHc effects
of NE a t the cellular level (For review see Lembo, 1996). The first
mechanism is supported by a report th a t there is a reduced effect of insulin
to stim ulate skeletal muscle blood flow in obese m en (Laakso e t al., 1990).
However, Capaldo et al., 1991 found th a t although skeletal m uscle is a
major site of insulin resistance in essential hypertension, the defect is
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independent of muscle blood flow. In a separate study, impaired insulinmediated augm entation of blood flow in obese NIDDM patients was
attributed to the diabetic state rath er th an the obese statu s (Laakso e t al.,
1992). O ther studies, however, also suggest increased sympathetic drive as
a prim ary influence in hypertension (Egan, 1989; JuHus, 1988; Reis, 1988).
Thus, sympathetic activity may influence insulin-mediated vascular
responses as well as contribute as a prim ary factor to precipitate
hypertension in the obese.
Insulin modulation of sympathetic-mediated vasoconstriction is

another avenue through which these systems m ay predispose to
hypertension, and has incited much interest and scrutiny. In two separate
studies, a marked increase in sympathetic activity (measured by
norepinephrine levels and/or muscle sympathetic nerve activity) evoked by
insulin did not produce changes in arterial pressure or forearm vascular
resistance in humans (Anderson et al., 1991; Lembo et al., 1992). These
observations support the hypothesis th a t insulin per se is able to blunt
sympathetic-induced vasoconstriction. In one study, fat-fed dogs exhibited a
loss of coronary artery vasodilation to local hyperinsulinem ia (Rocchini et
al., 1996). This is consistent with previous work showing reduced glucose
uptake in essential hypertensive individuals (N atali et al, 1991), and the
observation th a t this reduction may be due in large p art to an im pairm ent
in the action of insulin to increase skeletal muscle blood flow in obesity and
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hypertension (Baron et al., 1988; Laakso et al., 1992; Baron et al., 1991).
Investigations using LBNP and insulin infusion found th a t increases in
forearm vascular resistance normally observed w ith LBNP are blunted
during insulin infusion (Lembo et al., 1993). Biochemical studies have
demonstrated th a t insulin interferes w ith the az-adrenergic receptormediated vascular effects (Devedgian et al., 1991), while additional findings
seem to suggest th at it selectively interferes with transduction of the azvasoconstrictor signal (Lembo et al., 1994b ). A growing body of evidence
proposes th a t insulin's hemodynamic effects may be m ediated by enhanced
endothelial function (Steinberg et al., 1994; Scherrer et al., 1994). Thus it is
reasonable to propose th a t changes in the interaction of in sulin, endothehal
derived vasoactive factors (such as nitric oxide) and the SNS may modulate
vascular effects, thereby influencing the development of hypertension w ith
weight gain.
Nitric oxide (NO) is one vasoactive factor which m ay play a crucial
role in the complex relationships influencing vascular changes predisposing
to obesity-associated hypertension. In recent years, nitric oxide has come
under much scrutiny for its abihty to induce vascular relaxation and
reductions in peripheral resistance, and as a potential m odulator of nervous,
renal and immune system function. Initial studies suggest th a t the nitric
oxide system may be im portant in various organ system s for normal
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physiologie functioning, as well as having an instrum ental role in various
disease states.
Nitric oxide has been identified as the major functional component of,
or is identical to, the local vasodilator endothehal-derived relaxing factor
(Palmer et al., 1987; Ingarro et al., 1987). It is a nitroso compound derived
from the local oxidation of L-arginine (Palmer et al., 1988a, b; Sakum a et
al., 1988) by the enzymatic actions of nitric oxide synthase. Nitric oxide
synthase has been located in various body tissues in several isoforms which
have been purified and characterized (Forstermann et al., 1991). Nitric
oxide is reported to exist as either a constitutive or inducible enzyme in
many cells and tissues, including vascular endothehal cells, macrophages,
hepatocytes, the cerebellum and cerebrum, the pituitary gland, the nucleus
tractus sohtarius and the kidneys, to name a few (Forsterm ann et al., 1991;
Moncada et al., 1991; Bredt et al., 1990). AU isoforms require oxygen,
NADPH and 5,6,7,8-tetrahydrobiopterin as cofactors, w ith some variation
existing between isoforms as to other factor requirem ents and the nature of
the isoform as either a particulate or soluble type of enzyme (Forstermann
et al., 1991).
Competitive inhibition of NO synthesis has been achieved using Larginine derivatives such as L-N°-monomethyl arginine (Palmer et al.,
1988b; Sakuma et al., 1988). The potency of inhibition obtained using Larginine derivatives can vary, depending upon the tissue studied and the
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drug used. N -nitro-L-arginine was found to be more potent th an N methyl-L-arginine in inhibiting NO synthesis in the brain and endothelial
cells, b ut less potent in induced macrophages (Lambert et al., 1991; Gross et
al., 1990). Differences in potency between inhibitors were also
dem onstrated in a study by O kum ura et al., 1992, in which N^-nitro-Larginine (LNNA) was more potent in ehciting renal vasoconstriction th a n
was L-N^-monomethyl-arginine (LNMMA).
Endothelial NO acts via the stim ulation of soluble guanylate cyclase
to increase intracellular guanosine 3’, 5’-cyclic monophosphate (cGMP),
thereby inducing smooth muscle relaxation (for review see Bassenge and
Heusch, 1990; Moncada et al., 1991). Basal/continuous release of NO occurs
in the vascular endothehum, b u t a stim ulated release may be initiated by
several vasoactive substances such as acetylcholine or bradykinin, or by
mechanical stim uli such as pulsatile flow or shear stress (Bassenge/Heusch,
1990; Moncada et al., 1991; Rubanyi et al., 1986; Rees et al., 1989). These
characteristics of NO make it ideally suited for a role in acute and/or
chronic modulation of blood pressure and vascular resistance.
The vasorelaxing properties of NO have been directly dem onstrated
in several in vitro preparations (Moncada et al., 1991; Komori et al., 1988).
Recent in vivo studies have shown th a t NO synthesis inhibition using Larginine derivatives results in elevations of arterial pressure in dogs
(Manning et al., 1993 and 1994; Eisner et al., 1992), rats (Perrella et al..
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1991; Ribiero et al., 1992) and rabbits (Rees e t al., 1989). With NOS
inhibition total peripheral resistance increases as does renal vascular

resistance, w ith decreased renal plasm a flow, urine flow and sodium
excretion, but little change in glomerular filtration rate (Eisner et al., 1992;
Baum ann et al., 1992; Majid and Navar, 1992). However, in studies by
Salazar et al. (1992 and 1993), low doses of th e nitric oxide synthase
inhibitor N^-nitro-L-arginine-methyl ester (L-NAME) infused in dogs for 3

or 5 days caused ren al vasoconstriction, but did not result in hypertension
unless sodium intake was increased (Salazar et al., 1993). The results of a
study by Granger an d colleagues (1992) comparing intrarenal versus
systemic effects of NO blockade indicate th a t the renal effects of L-NAME
are largely secondary to extrarenal effects of NO inhibition, and
speculations were made as to a possible role of SNS activation. Thus, since
reduced sodium excretion and increased extracellular fluid volume have
been reported to occur with obesity-induced hypertension in dogs, and
increased catecholamine levels have also been suggested to occur with
obesity (Tuck et al., 1992; Rocchini et al., 1989b), the function of the nitric
oxide system deserves study as a possible m ediator of these changes during
the development or maintenance of hypertension in the obese.
The role of NO as a mediator of cardiovascular hemodynamics and
vascular responses in various models of hypertension has received much
examination, as acute and chronic NO inhibition results in increased
arterial pressure in several species, (Lockette et al., 1986; Panza et al..
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1993a, b; KoUer and Huang, 1994). Using three models of hypertension in
the rat, Lockette et al. (1986) showed a loss of endothelium-dependent
relaxation during development of hypertension, which they felt w as related
to the elevated blood pressure. In 1990, Panza et al. described abnorm al
vascular relaxation in patients with essential hypertension, whose forearm
response of blood flow and vascular resistance to acetylcholine (ACH), but
not sodium nitroprusside, were significantly lower th a n controls. This
impaired response to endothehal-derived vasodilators and the increased
basal vascular resistance in essential hypertension was later found to be
due, at least in part, to a defect in the NO system (Panza et al., 1993a, b),
but not related to decreased availabüity of substrate for NO synthesis
(Panza et al., 1993b). Diabetic subjects (NIDDM) are reported to have
attenuation of blood flow, which is reportedly due to either increased
inactivation of nitric oxide or decreased reactivity of the vascular smooth
muscle to NO (Wilhams et al., 1996). In the spontaneously hypertensive rat
(SHE), reductions in arteriolar dilation in response to increases in flow are
attributed to im pairment of the nitric oxide-mediated portion of flowdependent arteriolar dilation (Koller and Huang, 1994). Thus, d ata are
accumulating which link the function of the nitric oxide system to the
development of hypertension, although data are lacking which link altered
function of the nitric oxide system to obesity-associated hypertension.
In addition to the reports of abnormal responses to nitric oxide
blockade, essential hypertensive patients have decreased endothelial nitric
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oxide synthesis (Calver et al., 1992). Also, a positive relationship has been
reported between insulin sensitivity and endothehal nitric oxide synthesis
by P etrie et al., 1996 in a study examining forearm vasoconstrictor
responses to hyperinsulinémie euglycemia and NOS inhibition. Thus,
another mechanism through which NO may be associated w ith obesityinduced hypertension is through interaction w ith insulin. In a study by
W alker, et al. (1997) insulin attenuated the contractile response to
noradrenaline in rat mesenteric arteries. This effect was blunted by L-

NAME, supporting the idea th a t insulin's effect to reduce the
vasoconstriction induced by noradrenaline is nitric oxide dependent. This
group proposed several mechanisms through which L-NAME could work to
oppose the abihty of insulin to blunt norepinephrine-induced
vasoconstriction:
1) inhibiting NO synthase - probable
2) altering insulin binding
3) interfering with insulin metabohsm
It is possible to postulate th a t insulin-induced release of NO occurs at
physiologic insulin levels, resulting in tonic vasodilation. Insulin resistance
is known to occur in essential hypertension (Ferrannini et al., 1987). Thus,
developing insulin resistance may be associated w ith im paired insulininduced NO release and a loss of this tonic vasodilating stim ulus, with
subsequent development of hypertension (Baron, 1996).
An alternate interaction between NO and in sulin is suggested by
recent studies in dogs (Büski et al., 1995a and b) which report th a t NO m ay
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be a n im portant neurotransm itter in the pancreas. In these studies, Larginine infusion resulted in a significant increase in pancreatic protein
output (a reflection of exocrine pancreatic function), and LNNA caused
significant reductions in insulin and glucose. Their paradigm of LNNA use
alm ost abolished the increment of in sulin and glucagon in response to sham

and ordinary feeding. However, this LNNA infusion did not change basal
pancreatic protein secretion. They proposed th a t these effects were
probably mediated through cholinergic mechanisms, since direct cholinergic
stim ulation of insulin secretion w as blocked w ith the LNNA treatm ent.
O ther studies support the role of NO in both exocrine and endocrine
pancreatic secretion in humans (Konturek et al., 1997). In this study,
secretin and caerulin-stim ulated pancreatic enzyme secretion w as reduced
by LNMMA, w ithout alterations in volume flow and bicarbonate outputs.
Addition of LNMMA to the secretagogue infusion was associated w ith a
reduction in plasm a insulin and pancreatic polypeptide (PP) levels, while
addition of L-arginine raised insulin and PP levels above normal. This
supports a role for NO in pancreatic insulin secretion, another avenue
through which these two factors m ay interact. Thus, there are several
pathw ays through which the nitric oxide system and insulin m ay interact to
influence arterial pressure in hypertensive disorders. These require
exam ination in the obese model of hypertension as mediators of th is disease
syndrome.
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In addition to its involvement in cardiovascular hemodynamic
function, the role of the nitric oxide system in nervous tissue function has
been explored. Nitric oxide synthase activity has been identified in several
CNS locations (Bredt et al., 1990; Forstermann et al., 1991), and studies
exploring a regulatory role for NO in functioning of the sympathetic nervous
system have been performed (Harada et al., 1993; Sakuma et al., 1992). In
1991, Vo et al. dem onstrated th a t central inhibition of NO synthesis
enhances the vasoconstrictor responses to peripheral sympathetic nerve
stim ulation and adrenaline in the ra t tail artery. In 1993, H arada, et al.
examined the effects of microinjections of L-arginine into the nucleus
tractus sohtarius (NTS) on blood pressure, heart rate and renal nerve
activity. The results of this study suggests th at NO is involved in NTS
mechanisms th at mediate tonic renal nerve activity in rabbits, providing
support for central NO synthase activity in the regulation of renal
sympathetic nerve activity. Intravenous LNMMA adm inistration in
sinoaortic-denervated and vagotomized rats increased renal sympathetic
nerve activity (Sakum a et al., 1992), while Togashi and his colleagues,
ehcited elevations in arterial pressure and renal sympathetic nerve activity
w ith intra-cisternal injections of LNMMA (Togashi et al., 1992). These
studies further support central regulation of peripheral SNS activity by NO.
Thus, in addition to modulating vascular resistance by peripheral
mechanisms, NO m ay play a role in central regulation of sympathetic tone
and/or renal nerve activity.
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O ther experiments have suggested th a t sympathetic activation is in
tu rn a modulator of NO release (LacoUey et al., 1991). In 1991, LacoUey
suggested th at the SNS plays an im portant role in m odulating the synthesis
or release of vascular NO through the effects of normal sympathetic
discharge, humoral activation of a-adrenergic receptors and vascular tone
per se, since ganghonic blockade w ith chlorisondamine lowered mean
arterial pressure and vascular resistance, abolished the LNA-induced
pressor and renal vasoconstrictor responses, and attenuated the increase in
mesenteric and hindquarter resistance in rats. In 1992, Pegoraro et al.
suggested th at NO synthesis may be stim ulated by alpha-1 receptors due to
a greater response to NO synthesis inhibition in phenylephrine-pretreated
rats.
Thus, the role of NO synthase activity in central and peripheral
regulation of vascular, renal and nervous system control is complex. There
is clear evidence th a t central NO production can modulate sympathetic
nervous system activity as well as evidence th at peripheral sympathetic
activity can modulate both the production and the action of NO in
peripheral vessels. Although it is clear th a t these two systems interact, it is
not clear how, or if, they interact in the pathogenesis of hypertension in
either the lean or the obese state. The involvement of these two systems
w ith in sulin and insulin resistant disease states further compHcates the
mechanisms through which hypertension could develop w ith obesity.
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F urther study of this triad as modulators of obesity-hypertension is thus
w arranted.
The studies described in this dissertation were designed to examine
the interactions of insulin, the SNS and nitric oxide in lean and obesehypertensive dogs, further characterizing the mechanisms responsible for
the development of hypertension with obesity. This was accomplished using
the canine model of obesity-induced hypertension, the hyperinsulinémie
euglycemic clamp technique, nitric oxide synthase inhibition and unilateral
lum bar ganghonectomy to examine the following hypotheses.
1) The interaction of hyperinsulinemia and sympathetic activity were
examined over the course of weight gain to determine whether changing
vascular resistance is influenced by insulin or SNS activity, predisposing to
arterial pressure increases. We hypothesize th a t as insulin resistance
develops w ith weight gain, insulin’s effect to reduce vascular resistance is
decreased. At this time, increases in SNS activity associated w ith obesity
alter peripheral vascular resistance, laying a foundation for hypertension to
develop. Thus, in animals w ith nervous activity removed to one limb (while
the SNS of the opposite limb rem ains intact), we monitored insulin levels
and femoral vascular resistance (FVR) throughout weight gain to determine
w hether th e vascular response to weight gain correlated with insulin levels,
and were influenced by SNS innervation.
2) Local NOS activity reduces peripheral vascular resistance, but this
function m ay be reduced in the obese. Peripheral sympathetic activity may
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be im portant in m odulating vascular responses to nitric oxide, an d this
interaction may be altered in the obese animal. We hypothesize th a t the
increase in SNS activity which develops w ith weight gain may inhibit the
activity of vascular NOS, thereby predisposing to hypertension. Thus, the
vascular response to nitric oxide synthase inhibition in intact an d
denervated femoral arteries in the lean animals should vary slightly, due to
differences in basal tone resultant from nerve input. However, as
sym pathetic activity increases in obesity, there should be a reduction in
NOS activity in the intact femoral artery. Thus, inhibition of NOS should
induce a smaller vascular response in the obese intact limb compared to the
denervated limb, and widen any difference in FVR present betw een
innervated and denervated hmbs observed prior to w eight gain.
3)

Since interaction between insulin and NOS is also recognized, and

reduced response to both are observed in the obese, abnorm alities in this
interaction may occur in the obese and predispose to hypertension. If NOS
activity mediates vascular relaxation in response to insulin in lean animals,
an abnorm ality in this interaction may occur in obesity. We hypothesize
th a t a reduction in NOS activity occurs in the obese, reducing insulin's
ability to induce vascular relaxation, and possibly predisposing to
hypertension. Hyperinsulinemia in lean animals w ith normal NOS activity
should reduce vascular resistance, and NOS inhibition in this population
should decrease the vascular response to hyperinsulinem ia if it is indeed
m ediated through NO activity. However, in the obese, who have reduced
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vascular NOS activity, insulin m ay be unable to cause vascular relaxation
w hen NOS is inhibited, thereby predisposing to pressure/vascular resistance
increases. Sympathetic activity m ay also influence this response since it
m ay reduce NO activity. Thus, unilateral denervation technique during
these studies allows the exam ination of the SNS interaction.
The above hypotheses were studied in canine model of diet-induced
obesity (Rocchinni et al., 1987) by using the hyperinsulinémie euglycemic
clamp technique (HIEC; DeFronzo et al., 1979) and NOS inhibition in lean
and obese animals. The HIEC technique uses a constant rate insulin
infusion and a variable rate glucose infusion to examine insulin sensitivity
while maintaining euglycemia (Defronzo et al., 1979). This procedure raises
plasm a insulin levels acutely and then m aintains them at a new plateau
w ithout the complication of hypoglycemia (Defronzo et al., 1979). Thus, the
HIEC technique allows one to study physiologic effects of elevated i n s u l i n
levels (Liang et al., 1982) and determine sensitivity to insulin-mediated
glucose disposal. The HIEC procedure was performed alone and after NOS
inhibition to determine w hether interaction of insulin and NOS is an
im portant predisposing pathw ay for hypertension in the obese, and w hether
SNS activity influences the response to insulin.
The canine model of diet-induced obesity was used in these studies.
This model was described by Rocchinni et al. (1987) in a study in which a
high fat diet was fed for 5 weeks. During overfeeding, the anim als exhibited
significant weight gain which was associated with elevations in arterial
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pressure, h e a rt rate, plasm a volume, cardiac o utput and systemic vascular
resistance, as is also described in humans (Alexander et al., 1962; Mujais et
al., 1982, Rocchini et al., 1989a). Weight gain in the dogs was also
associated w ith hyperinsulinemia/insulin resistance (Rocchini et al., 1987),
as described in both obese and non-obese hypertensive hum ans (Ferrannini
et al., 1987). Thus, this is an appropriate model to study the development of
hypertension w ith weight gain (Rocchini et al., 1987 and 1989b). In our
laboratory, th is technique has been modified to include a specially
formulated diet with consistent ingredients, which can be prepared in both
a pelleted and powdered formulation. Also, once an animal refused to
consume the entire quantity of diet presented, the hquid m ixture was fed
via a gastrostomy tube to ensure the diet was received in its entirety.
U nilateral denervation of one hind limb (left) was utilized in these
experiments to study the interaction of the SNS and insulin on vascular
activity, and to provide an intact control within each individual. Removal of
nerve activity to one limb also allowed us to examine the role of sympathetic
activity in mediating the response to NOS inhibition and/or
hyperinsulinemia. Since the studies were performed in both lean and obese
dogs, we were able to examine whether the interaction of vascular SNS
activity, insulin and NO activity differed between lean and obese
individuals.
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C H A PT E R S: MATERIALS AND METHODS
A n im al c a re a n d p r e p a r a tio n :
The interaction of insulin, the sympathetic nervous system an d nitric
oxide (NO) in controlling femoral blood flow, arterial pressure and h ea rt
rate were examined in the conscious dog using chronically instrum ented
and unilaterally lum bar denervated animals. These experiments were
performed in conscious female dogs, spayed, lean and obese, walking slowly
on a treadm ill (<1.61 km/h; 0.44 m/s). All procedures and protocols were
approved by the Institutional Animal Care and Use Committee prior to
initiation.
The canine model of diet-induced obesity-related hypertension was
used in these studies, since these animals display metabohc, horm onal and
physiologic changes consistent with those observed in obese hypertensive
hum ans. These animals, although expensive to instrum ent and m aintain,
are an excellent model for studying relationships between hypertension and
obesity (Rocchinni et al., 1987). Their size allows long term vascular access
and telem etry recording w ith minimal stress.
A n im als: Ten 15-21 kg spayed female dogs were purchased from the
Louisiana State University School of Veterinary Medicine breeding colony.
This facility is approved for the breeding of anim als for research by the
United S tates D epartm ent of Agriculture. All animals were clinically
healthy prior to use, having negative heartworm antigen tests (Dirofilaria
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im m itis) and normal clinical chemistry profiles and hematology. The dogs
were housed in individual stainless steel metabolic cages w ith epoxy-coated
alum inum flooring. Each cage was fitted with an individual radiotelem etry
receiver (Data Sciences International, St. Paul, MN) for remote telem etry
data collection and storage via computer (IBM 386 computer using
D ataQ uest IV system software. D ata Sciences Intl., St. Paul, MN). The
cages were located in a tem perature controlled room (22 ± 1“C) w ith a
twelve hour light cycle (7:00A.M.-7:00P.M.).
T re a d m ill ac c lim a tio n : The method of walking during the acute
studies was instituted to mininiize variability between the a rte ria l flow of
the 2 pelvic limbs, w ithout the need for anesthesia or tranquilization.
Several different regimes of sedation/tranquilization or general anesthesia
were explored prior to the use of this method. However, none of these
protocols provided adequate anim al restraint, while allowing the
m easurem ent of stable femoral blood flow or arterial pressure over the time
required for completion of the acute HIEC studies. Thus, the stability of
femoral artery blood flow was assessed while walking, as were h e a rt rate
(HR) and m ean arterial pressure (MAP). Since these param eters were
found to rem ain stable while walking, the acute studies were performed
w ith the animals slowly walking on a treadmill a t < 1.6 km/h (0.44m/s).
The dogs were acclimated to standing and walking on a treadmill
(model #1849-01, Quinton Instrum ent Co., Seattle, WA) prior to beginning
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the studies. The animals were placed on the treadmill, allowed to stan d
quietly, th en the treadmill started (<1.6 km/h; 0.44 m/s). The length of time
spent walking was slowly increased as the dogs began acclimating/relaxing.
The am ount of time required for acclimation depended upon individual
personality and behavior. The acute studies were not performed u ntil each
animal walked comfortably on the treadmill.
C h ro n ic In s tru m e n ta tio n a n d s u rg ic a l p ro c e d u re s : All animals
had instrum entation surgically im planted in the following manner:
1. A chronic indwelling jugular catheter was surgically placed for
vascular access. A hand made sialastic® (Dow Coming, Midland, ME)
catheter was inserted into the left jugular vein, w ith the remaining tubing
tunneled subcutaneously to the cranial-dorsal thoracic region where it was
connected to a subcutaneous access port.
2. A remote telemetry catheter (Data Sciences International, St. Paul,
MN) was placed into the left carotid artery of each anim al for continuous
monitoring of arterial pressure and h eart rate. The associated battery unit
(model# TA11PA-D70) was placed subcutaneously in the lateral cervical
region. Each animal was housed in a metabohc cage equipped w ith its own
telemetry receiver through which d ata was collected and transm itted to an
IBM 386 computer for continuous d ata collection.
3. A stainless steel peg gastrostomy tube (Associated Technologies
and Manufacturing Inc., Baton Rouge, LA) was placed into each anim al
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through a ventral midline celiotomy. The tube was exteriorized through the
ventro-lateral abdominal wall, caudal to the thoracic rib margin.
4. Bilateral ultrasonic tran sit time perivascular flow probes (model
4RS, w ith a CM4B connector, Transonic Systems Inc., Ithaca, NY) were
positioned around the proximal femoral arteries. The attached cable and
connector were tunneled subcutaneously to the dorsal mid-cervical region
and placed in a subcutaneous pocket until exteriorized ju st prior to the first
acute experiment. Following exteriorization the cables and connectors were
placed in a denim collar to prevent destruction. The collar was changed and
the os flushed routinely with dilute nolvasan solution or antibiotics to
minimize infection.

During acute protocols, the probe connectors were attached to a T206
flow m eter (Transonic Systems, Inc., Ithaca, NY) and the femoral blood flow
(FBF) d ata stored on an IBM S33 personal computer using DATAQ data
acquisition software (Dataq Instrum ents, Inc., Akron, OH). Femoral
vascular resistance was calculated firom flow using FVR=MAP/FBF.
5. Via a ventral midline celiotomy, the animals underwent a
unilateral surgical lumbar sympathectomy (left side, La-Le) as described for
hum ans by Callander et al., 1958. Removal of the La-Le lumbar ganglia in

dogs has been shown to provide complete sympathetic denervation of the
pelvic limbs (Carey et al., 1967), and has been used in the dog to study
femoral blood flow (Crononwett et al., 1977; Galt, et al., 1991).
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The animals underw ent a total of 3 surgical operations. The jugular
catheter and the telem etry unit were placed during one surgery. The La-Le
ganghonectomy and gastrostomy tube placement were performed together
during a separate surgery, and bilateral femoral flow probes were placed on
yet another occasion. Each pre-surgical and surgical procedure was
conducted as follows. Following a 12-18 hour fast, each anim al was
premedicated w ith acepromazine maleate (Promace®; Fort Dodge
Laboratories, Inc., Fort Dodge, lA: 0.02-0.2 mg/kg, i.m.; 0.3 mg maximum)
then anesthesia was induced using thiopental sodium (Pentothal®; Abbot
Laboratories, North Chicago, IL: 4-6 mg/lb, i.v. to effect). Throughout
surgery the anim als were m aintained on 1.5-3% isoflurane inhalant
anesthesia (Aerrane®; Ohmeda Caribe Inc., Guagama, PR) as individual
requirem ents dictated. The animals were placed on circulating w ater
heating pads to m aintain body tem perature during surgery and recovery.
Intra-operative polyionic fluids and antibiotics (Cefazolin®, 1 gram in fluids)
were administered.
Analgesics were not required in the postoperative period by any
animal. However, flunixin meglumine (Banamine®; Fort Dodge
Laboratories, Inc., Fort Dodge, LA: 1.1 mg/kg, i.m.) was empirically
adm inistered during the recovery period of the combination
denervation/gastrostomy surgery, to reduce postoperative inflam m ation and
discomfort which may have resulted from visceral manipulations required to
access the ganghonic chain and perform the La-Le ganghonectomy an d the
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tube-gastrostomy. Antibiotics were administered (TMPS®; Sidmark
Laboratories, Inc., E ast Hanover, NJ: 30 mg/kg; per os, BID) for a m inim um
of three days following surgery. A minimum of 1-2 weeks of recovery was
allowed, depending upon the procedure performed, the sequence of th e
surgeries for each anim al and their individual recovery rates. AU surgical
manipulations were performed a t least one week prior to any acute infusion
study, and a minimum of 2-2.5 weeks was aUowed foUowing denervation
prior to experimentation. Indwelling catheters were flushed weekly w ith
heparinized saline (lOOU/ml) to maintain patency.
D iet m a n ip u la tio n s : W ater was available, free choice, at all tim es.
The anim als were initiaUy fed Purina Dog Chow® (21% protein, 49.2%
carbohydrate, 8% fat, 4.5% fiber) once a day to m aintain stable body weight.
FoUowing weight m aintenance on Purina Dog Chow®, and prior to
beginning the acute studies, a speciaUy formulated peUeted diet was
introduced (Table 1; total protein 26%, total carbohydrates 62%, to tal fat
12%). This peUeted diet was fed a t the quantity calculated to provide the
equivalent number of Kcal of energy provided by the Purina® dog chow
required during stable weight maintenance. If necessary, the quantity of
peUeted diet fed was adjusted to maintain stable body weight. The anim als
were weight stable for a least 1 week prior to the acute lean experiments.
The lean animals were m aintained weight stable on the custom peUeted diet
(Table 1) without additional fat. FoUowing completion of the acute lean
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Table 1: Custom canine diet #D72204. Diet #D72204 was formvdated by
Research. Diets Inc., New Brunswick, NJ.
Ingredient
gm
kcal
200
800
Casein
Soy protein
50
200
DL methionine
3
0
175
700
Sucrose
Dextrose
360 1440
Maltodextrin 10
50
200
Cellulose
40
0
Xanthan Gum
10
0
Com Oil
50
450
Salt mix S70003
50
0
Vitamin mix V90001
10
40
Choline b itartrate
2
0
TOTAL
1000 3830

experiments, the lean animals were overfed a powdered formulation of the
custom diet, to which melted lard was added to increase the energy intake
to 150% above maintenance. The animals were acclimated to the higher fat
food by increasing the fat content to 50%, 100% and 150% above
maintenance levels over several days. The animals initially were allowed to
eat the diet a t will, then fed via the tube-gastrostomy once th eir appetite
waned. This overfeeding paradigm produces significant increases in body
fat over 5-7 weeks (approximately 25%-50% increase in body weight),
without the development of intractable diarrhea, vomiting, or pancreatitis.
All lean anim als were weight stable for at least one week prior to the acute
studies. At the end of the 7-week overfeeding period (during the acute obese
experiments) each anim al was maintained weight stable by feeding the
powdered-diet and lard mixture to provide 50% above calculated
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maintenance energy requirements. This individual feeding regimen was
adjusted by adding or reducing the lard content to ensure weight stability
during the acute post-obesity protocols.
B ody w eig h t, b o d y co m p o sitio n a n d MAP/HR m o n ito rin g :
Body weight was measured in the fasted anim al three tim es per week
throughout the studies. Dual-energy x-ray absorptiometry (DEXA; Hologic
model QDR-2000, Waltham, MA) was performed in anesthetized anim als at
the end of the lean studies and again prior to the obese protocols. DEXA is
a technique for directly assessing body composition using dual x-ray beams
of differing energy levels which are differentially absorbed by tissues
varying in density (Jensen et al., 1993). A rterial pressure and heart rate
were monitored continuously via telemetry throughout the pre-obesity
experimental study period and during the overfeeding period. However, to
minimize external environmental influences on blood pressure and heart,
only data collected between 7:00 p.m. and 7:00 a.m. (over-night) was used
for daily averages.
A n aly tical p ro c e d u re s:
P lasm a in su lin ra d io im m u n o a ssa y : Insulin levels in plasma
were measured using radioimmunoassay kits purchased from Linco
Research, Inc. (St. Charles, MO). Canine standards were ru n in triplicate
w ith each assay, and all subject samples and canine quality controls were
run in duplicate. All samples from both the lean and obese
hyperinsulinémie euglycemic clamp (HIEC) and the hyperinsulinémie
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euglycemic clamp performed following nitric oxide synthase inhibition
(LNA-HIEC) of each anim al were run w ithin one assay (n=2 assays w ith
three animals per assay) and weekly sam ples for all anim als and all weeks
were run in a single assay. Intra- and inter-assay coefGcients of variation
were 4% and 7% respectively.
The protocol followed for plasma in sulin determ ination was the
standard insulin RIA procedure followed for canine samples in our
laboratory. In short, 100 pi of standards or samples were separately
pipetted into borosihcate culture tubes a n d 100 pi of assay buffer, th en 1®‘
antibody (guinea pig anti-porcine insulin serum) were added. One hundred
pi o f 1^25 insulin trace was added to each tube. The samples were incubated
overnight, then 100 pi of the

antibody (goat anti-guinea pig IgG) and

carrier (normal guinea pig IgG) were added and the sam ples incubated for 2
hr a t 4“C. One ml of w ash buffer was th e n added to stop th e reaction and
all samples were centrifuged a t 3,000 RPM for 25 min a t 4°C. The
supernatant was carefully poured off an d th e samples were allowed to dry
and the activity was determ ined using a gam m a counter (model 5500B,
Beckman Instrum ents Inc., Fullerton, CA).
P lasm a glucose a n a ly sis : P lasm a glucose concentrations were
determined using a YSI model 2700 glucose analyzer (Yellow Springs
Instrum ents, Yellow Springs, OH), which utilizes the glucose oxidase
method. The normal range of plasma glucose concentrations for our
animals was 90-108 mg/dl, for studies 3 an d 4 combined.
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T issu e c a te c h o la m in e levels: At the termination, of all studies,
femoral artery sections (3-4 artery sections per limb) were removed an d
tissue catecholamine levels assessed. Femoral artery tissue samples were
recovered immediately from the animals following euthanasia. Left limb
(denervated) samples were taken first to reduce the chance of lowering
quantities of catecholamines due to the rapid metabolism. The samples
were placed into chilled 0.1 M perchloric acid and immediately frozen in
hquid nitrogen. During the homogenization procedure a total of 1.5 m l of
perchloric acid was added to the volume during flushing of tubes. Tissue
homogenization was performed on the same day as collection in all b u t one
animal, using a tissue homogenizer from Omni Inc (Warrenton, VA). In this
animal the homogenizer broke at the sta rt of the first sample so

homogenization was postponed until a replacement was obtained (8 days).
Tissue homogenates were assayed using high performance liquid
chromatography (HPLC) to determine tissue catecholamine levels. These
assays were performed by Dr. Gennady Smagin using the standard
techniques of his laboratory. In short, tissue homogenate supernatant (0.5
ml) was extracted using 50 mg acid washed alum ina and TRIS buffer/EDTA
(1.5 M, pH 8.6). Samples were analyzed (50 pi injection volume) for
neurotransm itter (NE and E) concentration using an HPLC system
consisting of a pump (model 420), autosampler (model 460), Coulochem
detector (model 5100A), high performance analytical cell (model 5014), and
MD-150 column (all from ESA, Inc. Bedford, MA). The mobile phase
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consisted of 75 mM NaH2P04, 1.4 mM l-octenesulfonic acid sodium salt
monohydrate (OSA), 10 |iM EDTA, 10% acetonitrile adjusted to pH 3.1 with
H 3 PO 4 . The flow rate was m aintained at 0.9 ml/min. Minor changes of pH
and OSA concentration were made to obtain optim al separation. Detector
potentials were set a t -0.04 V for electrode 1, +0.35 V for electrode 2 and a t
+0.4 V for the guard cell. Data were collected by a Kontron IBM-PC-based
integrator (ESA, Inc, Bedford, MA), and the integrated d ata were
transferred directly to a spreadsheet program for data analysis.
Appropriate extracted catecholamine standards were prepared
(NE/arterenol and E/adrenalin, Sigma, St. Louis, MO) and ru n (150 pi
injection volume containing 2.14 ng of NE and E) with the samples. All
samples for each anim al were ru n within the same assay. The laboratory
inter-assay coefficient of variation for the catecholamine HPLC assay is
<5%. Before samples were processed, assay vahdation was performed. This
validation was performed by extraction of 100, 50, 25, 10, 5, an d 0 ng/ml of
NE. N-methyl-D-aspartate (NMDA) was used as the internal standard.
The peak height of NE was measured and the ratio of NE to the internal
standard was determined. This ratio should rem ain constant a t varying
concentrations, and the linearity of the ratio was checked for validation.
Once linearity was validated, samples were analyzed, with single point
calibrations (using lOng/ml of NE) used for daily quantitation of samples as
long as no system components were changed. The concentration of NE in
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the samples were in the range of 1-10 ng/ml of extract, and w ithin the
validated linear range.
A c u te e x p e rim e n ta l p rotocols:
All acute experiments were performed in lean fasted anim als (12-18
hour fast) and repeated in the same animals after seven weeks of
overfeeding. H eart rate (HR), arterial pressure (BP) and femoral blood flow
(FBF; used to calculate femoral vascular resistance, FVR) were m easured
throughout the studies. Following a 5-10 minute acclimation period, twenty
m inutes of walking baseline data were obtained a t the beginning of all

experim ental studies. The drug doses calculated for these studies were
based upon the weight of each dog on the date of the study (i.e. lean wt. or
obese wt.). If necessary, a study w as repeated based on data work-up, or if
stable glucose levels could not be achieved w ithin 120 min of initiating the
hyperinsulinémie euglycemic clamp (HIEC) for studies 3 and 4.
S tu d y 1: Tim e c o u rse for th e d e v e lo p m e n t o f v a s c u la r re s is ta n c e
c h a n g e s a n d in s u lin re s is ta n c e w ith o b esity . To determine the time
course of vascular resistance changes with the development of obesity, and
w hether these changes occur concurrent with changes in insulin levels, we
monitored fasting insulin levels and vascular resistance changes throughout
the development of obesity. Prior to and during th e 7-week period of
overfeeding, 10 ml of blood was obtained weekly from each anim al, in the
fasted state. On the same day blood was drawn, the a n i m a l s were placed
onto the treadmill (<1.6 km/h; 0.44 m/s) and 30 m in of BP/HR/FBF d ata
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were recorded (10 min acclimation and 20 m in of stable recordings).
Changes in arterial pressure, heart rate, FVR and fasting insulin were
compared prior to the sta rt of overfeeding and weekly throughout the
development of diet-induced obesity.
S tu d y 2: C a rd io v a s c u la r p a r a m e te rs fo llo w in g N O S in h ib itio n w ith
LNA. Once 20 min of stable baseline d a ta was collected, 10 mg/kg of nitroL-arginine (LNA; a competitive inhibitor of nitric oxide synthase; Aldrich
Chemical Co., Inc., Milwaukee, WI) w as adm inistered through the
indwelling jugular vein port. Walking on the treadmill (<1.6 km/h; 0.44
m/s) w as continued for 2 hours following LNA adm inistration while
continuously recording BP/HR/FBF. At the end of this study, L-arginine
(bolus dose of 150 mg/kg, iv) was adm inistered to reverse the lasting effects
of LNA (Eisner et al., 1994). Nonetheless, a minimum of 5-7 days was
allowed for recovery of BP/HR/FBF response subsequent to LNA studies.
S tu d y 3: T h e h y p e rin s u lin é m ie e u g ly c e m ic clam p (H IEC) in le a n
a n d o b e se dogs. Once stable baseline w alking cardiovascular d ata was
collected, a hyperinsulinemic-euglycemic clamp procedure (HIEC; DeFronzo
et al., 1979) was performed in each anim al in the following manner. D uring
the 20 m in walking baseline period blood sam ples were obtained a t -15, -10
and -5 m in (1-1.5 ml obtained through the jugular access port), placed into a
heparinized micro-centrifuge tube and centrifuged to separate plasm a and
cells. The plasm a was immediately analyzed for glucose concentration (YSI
glucose analyzer model 2700, Yellow Springs Instrum ents, Yellow Springs,
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OH), and the rem aining plasm a w as stored for insulin assay by RIA. The
average of the -15,-10 and -5 min glucose samples was used as the baseline
value for th a t animal, and the ± 5% glucose range was calculated. The
infusion lines were primed w ith both insulin and glucose. At t=-5 m in the
insulin infusion was begun at a prim ing rate of 1.5 ml/min for 5 min. At the
t=0 point, the insulin infusion rate was reduced to 1.0 m l/m in for an
additional 2 min, and a t t=2 min, the rate was set to 0.5 m l/m in in s u lin (40
mU/min) for the rem ainder of the study. Glucose (30% solution in sterile
water) was concurrently adm inistered at an initial priming rate of 1.0
ml/min for 1 min (starting a t t= -l min). At t=0, the glucose rate was
reduced to 0.5 ml/min and adjusted as necessary thereafter to m a in ta in
plasm a glucose levels w ithin a ± 5% range of the baseline average. Both
insulin and glucose infusions were administered through a cephalic vein
catheter using syringe pumps (model #22, H arvard A pparatus, Southnatick,
MA). Blood samples (1.0-1.5 ml) were obtained every 5 m inutes from the
jugular access ports to monitor plasm a glucose concentration, allowing
adjustm ent of the glucose infusion rate to m aintain euglycemia (90-108
mg/dl). The rem aining plasm a was saved for in s u lin assay.
Once glucose was stabilized within 5% of baseline, FBF/BP/HR data
were collected for 2 0 -3 0 min while the a n im al continued a slow w alk (< 0 .4 4
m/s). Each study ended when 5 -7 consecutive stable glucose samples were
obtained th a t were w ithin the ± 5% baseline range. This allowed a
minimum of 3 0 -3 5 min of data collection while glucose was w ithin 5% of the
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baseline. Thus, the most stable 20 min could be used for statistical
comparison.
During the HIEC protocols (alone and under NO inhibition) 25 lU / ml
of heparinized saline (2.5 ml) was flushed through the sampling lines
following sample withdrawal. Prior to all sample withdrawals, 2.0 ml of
flush/blood mixture was w ithdraw n from the sampling line and discarded.
Another 3 ml of blood was removed to ensure th a t no flush rem ained in the
collection line. The 1.5 m l blood sample to be used for glucose and in sulin
analysis was th en withdrawn, the initial 3 ml was returned to the anim al
and the Hne was flushed w ith 2.5-3.0 ml of heparinized-saline solution (25
lU/ml). Thus, in these extended length protocols, the maximum am ount of
heparin adm inistered was approximately 25-40 mg for the 2+ hour studies.
The higher level is within the recommended initial loading dose for
anticoagulant therapy w ith heparin in dogs. Removal and discarding of the
initial 2.0 ml of blood before sampling made the actual am ount of heparin
rem aining w ithin the anim al significantly less th an that calculated. These
steps were teiken to reduce any possible effects th a t may occur in fatty acid
metabohsm or hepatic clearance resulting from elevated levels of heparin.
No signs of coagulation defects were observed following any protocol. The
maximum volume of blood w ithdraw n from any individual was
approximately 40-50 ml (for a study lasting a full two hours). This volume
w as neghgible in this size dog, especially in light of the fluids being replaced
w ith the insulin and glucose infusions.
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Both, glucose and insulin infusions were adm inistered through a
cephalic vein catheter, and the blood samples were obtained through the
jugular access port. At the termination of each study, th e plasm a samples
were frozen at -20°C u n til assayed for insulin. A minimum of 48 h r was
allowed between any HIEC study and another study.
S tu d y 4: T h e H IE C fo llo w in g n itr ic o x id e s y n th a s e in h ib itio n (LNAH IEC ) in le a n a n d o b ese dogs. These studies were carried out exactly as
for the HIEC previously described in Study 3, with the following additions.
Once baseline walking cardiovascular d ata were collected, the treadm ill was
halted and nitro-L-argine (LNA; a competitive inhibitor of nitric oxide
synthase; Aldrich Chemical Co., Inc., Milwaukee, Wl; 10 mg/kg, iv) was
adm inistered. The dogs were allowed to stand or sit a t will for 45 m in,
while w aiting for cardiovascular param eters to change and stabilize
following LNA adm inistration. The treadmill was th e n restarted (<1.6
km/h; 0.44 m/s) and another walking baseline was obtained under the
influence of NOS inhibition. During this stable 20 m inute baseline of LNAwalking, the -15,-10 and -5 min baseline glucose/insulin blood sam ples were
collected from the ju g u lar catheter access port, as described in the original
clamp protocol. Thereafter, the HIEC protocol was performed exactly as
described for Study 3 [i.e. initial priming of both in sulin and glucose
followed by a constant insulin infusion of 0.5 ml/min (40 mU/min) a n d a
variable glucose infusion rate adjusted to m aintain euglycemia]. A
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m inim um of 5-7 days was allowed between any LNA study and another
study.
Statistical analysis:
All statistical analyses were performed by the Biostatistics
D epartm ent of the Pennington Biomedical Research Center, using PROC
MIXED or PROC GLM in BAS, version 6.12. In all multiple comparisons, pvalues were adjusted w ith respect to Tukey-Kramer or Bonferroni
inequalities as specified below.
Body composition w as analyzed using univariate analyses (t-test on
the leanrobese difference) comparing lean and obese DEXA scan results.
Change in body weight w ith overfeeding was analyzed w ith a mixed
statistical model and autoregressive covariate structure (assum ing equal
week to week variances and thereby reducing the number of unknown
param eters in the model), w ith baseline weight as a covariate in the model.
Body w eight was the dependent variable in the model, regressed over tim e
in weeks. Additionally, the weekly change compared to baseline was
assessed using the same model structure, w ith the difference in weight
between each week and the baseline as the dependent variable and tim e
(week) as the fixed effect.
The change in insulin during the overfeeding period (main effect of
time in weeks) was analyzed using a mixed model with weekly in s u lin
concentration as the dependent variable regressed over tim e (in weeks), for
7 dogs and over 8 weeks. In addition, the change in insulin concentration
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ôrom baseline for each, week of overfeeding was analyzed using a mixed
model w ith an autoregressive covariate structure ( a s s u m in g equal week to
week variances to reduce the number of unknowns in the model) for 7 dogs
and 7 baseline to week differences (the dependent variable was the
difference in in s u lin between baseline and each week of overfeeding, with
week as the fixed effect in the model). Other weekly data (MAP, HR and
FVR) were analyzed in a similar m anner, determ ining the main effect of
time as well as weekly change. For aU of these weekly param eters, if the
baseline param eter measure was determined to be a significant covariate in
the model, it was included as such. For FVR, combined data were analyzed
to determ ine whether differences between the limbs (denervated and intact)
developed over time for either position (standing an d walking ). Then, each
limb w as analyzed separately, for each position, for m ain effect of time and
weekly difference firom baseline. The positions and limbs were analyzed in
this way (separately) due to the complexity of the model when all variables
were included together. Correlation analyses (insulin with weight, HR,
MAP and FVR [intact and DNX]) were performed for each a n im a l and the
group.
In the study examining cardiovascular param eters and stabilization
following LNA (Study 2) data were analyzed using the mixed model with
autoregressive structure and baseline param eter level as a covariate, to
determ ine whether each param eter showed a significant time effect after
LNA adm inistration (model variables of weight group-lean and obese).
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Once it was determined th a t the cardiovascular param eters remained stable
following acclimation to treatm ent w ith LNA, all post-LNA data points were
combined for pre-LNA and post-LNA comparisons and for the analysis of
differences in response between weight groups. The dependent variable in
this mixed model was the difference between pre-LNA and post-LNA
param eters of HR and MAP for 6 dogs and comparing two weight groups
(lean and obese). This model used an unstructured covariate design (does
not assume equal variances of the covariate matrix thus) w ith weight group
and treatm ent period as the fixed effects, covariate param eter estim ation
and Tukey-Kramer adjustm ent for multiple comparisons. For FVR, the
difference between the two limbs was assessed, then the individual limb
response to treatm ent was separately analyzed and weight groups
compared, due to the complexity of the model and the num ber of
variables/sources of error. In these analyses, weight group, limb (intact or
DNX) and treatm ent period were the fixed effects in the model
In the HIEC and LNA-HIEC studies (Studies 3 and 4), the difference
in response between the two studies in both weight groups was analyzed
w ith each param eter as a dependent variable (HR, MAP, DNX-FVR, intactFVR), and an unstructured covariate structure with fixed effects and
covariate param eter estimation. D ata were analyzed for two weight groups,
LNA-HIEC and HIEC studies and n=6 dogs. In addition, the differences in
response to treatm ent (difference between baseline and hyperinsulinemia)
between weight groups were analyzed for each study separately, again
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using a mixed model w ith unstructured covariate design (as described
above), covariate param eter estimation and Bonferroni adjustm ent for
multiple comparisons.
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CH A PTER 4: RESULTS
Ten anim als were originally instrum ented for inclusion in these
studies. However, only 7 anim als finished the overfeeding regimen, an d 6
finished all obese acute experiments, due to unilateral or bilateral fem oral
flow probe failure.
The weekly body weight of the dogs increased significantly during the
7-week overfeeding period (Figure 2; Table 2). Although lean body m ass
(LBM) did not change significantly with overfeeding, the total grams of fat,
% fat and bone mineral content (BMC) increased significantly (Table 2).
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“ D ata are group means ± standard error of the mean (SEM) for n=7 dogs.
* Significantly different from baseline, p<0.01.

Figure 2; Change in body weight over the 7-week overfeeding period. ®
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Table 2: Body composition prior to (Lean) and following (Obese) 7 weeks of
o v e r f e e d i n g . ® ___________ _____________ _____

■

19.9 ± 0.7
B ody w e ig h t (kg)
29.7 ±
±
4.53
0.84
B ody fa t (kg)
14.64 ±
23.0 ± 3.65
% B ody F a t
48.8 ±
14.39 ± 0.63
LBM (kg)
14.73 ±
0.53 ± 0.02
0.57 ±
BMC (kg)
“ Data are group means (n=7) ± standard error of the
ns = not significant

0.77
0.81
1.95
0.49
0.02
mean

<0.001
<0.001
<0.001
ns
p=0.01
(SEM).

Postmortem femoral artery norepinephrine levels of the obese dogs
were significantly different between the denervated (270.13 ± 90.5 ng/g) and
intact (627.3 ± 108 ng/g; p=0.028) limb femoral arteries. This confirms
reduced femoral artery catecholamine levels (as a reflection of SNS activity)
in the denervated femoral artery during post-obesity studies.
Study 1: Time course for the development of vascular resistance
changes and insulin resistance with obesity.
In th is study, weekly comparisons of MAP, HR and FVR were made
w ith the anim als standing and walking on the treadmill. Fasting plasm a
in sulin levels were also assessed. There was a significant increase in MAP

over the 7-week period of overfeeding (significant m ain effect of time; Figure
3) in both th e standing (p=0.022) and walking positions (p=0.022).
However, using direct week to baseline comparisons, only the MAP in week
7 (standing) did the difference firom baseline approach significance
(p=0.056).
H eart rate also increased over the 7-weeks of overfeeding (significant
m ain effect of time, p=0.008; Figure 4). However, only in week seven was
the HR significantly increased over baseline while walking ^=0.012).
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H eart rate during week 1 decreased significantly compared to baseline
(p=0.03 for standing and walking).
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Figure 3: MAP during the 7-week overfeeding period.
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Figure 4: Heart rate during the 7-week overfeeding period.
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There was a significant overall time effect on FVR in the standing
(p=0.0407) and walking ^=0.0001) positions (Figure 5) for the denervated
and intact Hmbs. Standing FVR of the denervated limb was significantly
greater than baseline during weeks 1-2 of overfeeding, whereas FVR of the
intact limb was significantly greater th an baseline in weeks 1-5 (Figure 5).
In the walking state, both the denervated (p=0.0173) and intact limbs
(p=0.0074) showed a significant time effect of high-fat feeding. However,
compared with baseline walking FVR, only the intact limb showed
significant increase over baseline during week 1, (p<0.0395).
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Figure 5: Femoral vascular resistance during the 7-week overfeeding
periodFasting plasma insulin levels increased significantly during the
overfeeding period (main effect of time, p=0-04; Figure 6). Baseline insulin
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concentration ranged from 5.0-12.4 lU/ml in these dogs, w ith a significant
increase from baseline observed by week 2 of overfeeding Op=0.04).
However, significant correlation between insulin and the cardiovascular
param eters was not observed, and a very weak correlation of insulin w ith
body weight was present (r=0.346; p=0.0161). Only w eak correlation was
evident between body weight and cardiovascular param eters (MAP:
r=0.314, p=0.0281; HR: r=0.378, p=0.0075; DNX-FVR: r=-0.295, p=0.0398;
intact- FVR: r=-0.295, p=0.052). The strongest correlation present w as a
negative correlation between heart rate an d FVR of both limbs (DNX limb r
=-0.71 and intact limb r=-0.75; p=G.0001 each).
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* Significantly different firom baseline,*p<0.05;**p<0.01. Data are group mean ± SEM, n=7.

Figure 6: Weekly fasting plasm a insulin levels during the overfeeding
period.
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Study 2: Cardiovascular parameters following NOS inhibition with
LNA.
Following the initial response to LNA, all param eters (MAP, HR and
FVR) stabilized following NOS inhibition (Figures 7, 8, and 10). Thus, the
post-LNA treatm ent data were averaged for statistical comparisons, as were
data from the tw enty minute pre-LNA period.
Mean arterial pressure did not differ between lean an d obese dogs
during the pre-LNA (20 min average for lean, 97 ± 10 mmHg; obese, 107 ±
3.0 mmHg) or post-LNA treatm ent periods (lean, 115 ± 1.5 mmHg; obese,
123 ± 0.65 mmHg). Following LNA administration, MAP increased
significantly and stabilized in both weight groups (Figure 7). The MAP
response to LNA did not differ between the weight groups.
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Figure 7: MAP response to NOS inhibition in lean and obese dogs.®
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H eart rate (Figure 8) differed significantly between the lean and
obese dogs during the pre-LNA period ^=0.0007; 20 min average for
lean=107 ± 4 BPM, and obese=130 ± 4 BPM) and post-LNA period
(p=0.0001; 90 min average for lean, 75 ± 1 BPM; obese, 107 ± 1 BPM).
Although HR decreased significantly in both weight groups following NOS
inhibition, p<0.01 for each (Figure 8), the HR response to LNA
adm inistration was attenuated in the obese animals (Figure 9; p=0.02 for 32
BPM average HR decrease in the lean and the 24 BPM reduction in HR for
the obese).
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Figure 8: H eart rate response to NOS inhibition in lean and obese dogs.®
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Figure 9: Change in heart rate following LNA adm inistration
Pre-LNA femoral vascular resistance did not differ between the lean
and obese dogs (Figure 10). Also, pre-LNA FVR did not differ in th e DNX
and intact limbs in either weight groups. However, following LNA
adm inistration FVR differed between the weight groups (p=0.0086 for main
effect of weight), and between the intact and denervated limbs (p=0.0048,
for m ain effect of hmb). Femoral vascular resistance increased significantly
in both the DNX and intact limbs of the lean anim als following LNA
adm inistration (DNX, p= 0.01; intact, p=0.02). The increase in FVR in the
obese group did not quite reach significance (DNX, p=0.06; intact, p=0.051).
In the lean anim als during the post-LNA period, DNX limb FVR w as
significantly higher compared to the intact limb (p=0.002; Figure 10).
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However, this was not so in the obese. Additionally, FVR in the denervated
limb of the lean dogs was higher th a n the obese during the Post-LNA period
(p=0.02; Figure 10). Thus, the FVR response following LNA adm inistration
was significantly different between the lean and obese dogs Op=0.0135).
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Figure 10: Femoral vascular (FVR) response to NOS inhibition in lean and
obese dogs.
Studies 3 and 4: The hyperinsulinémie euglycemic clamp, alone
(HIEC) and following NOS inhibition with LNA (LNA-HIEC).
Glucose levels were not significantly different between the lean and
obese animals during the walking baseline period or during the stable
euglycemic hyperinsulinémie period in either study (Table 4). During the
stable hyperinsulinémie euglycemic period of the HIEC study, the glucose
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infusion rate of the lean a n im a ls was a lm o s t twice th a t of the obese (GER**HIEC; Table 3). In the LNA-HIEC, during which NOS w as inhibited prior
to the HIEC, the lean-obese difference in glucose infusion ra te was not
evident (GIR‘’-LNA-HIEC). In the obese, the difference in GIR between the
two studies was minimal (obese GIR*’-HIEC vs. obese GIR^-LNA-HIEC;
Table).
Table 3: Plasm a glucose» levels in lean and obese dogs during th e HIEC and
LNA-HIEC studies.
■
P re-H IE C
99.0 ± 1.63
98.7 db 0.73
H IE C
96.9 ± 2.91
99.1 ± 1.28
Pre-LN A -H IEC
97.4 ± 1.97
99.4 ± 2.21
±
LNA-HIEC
98.2
2.57
97.7 ± 2.33
GIRb-HIEC
0.45 ± 0.12
0.26 ± 0.09*
GIRb-LNA-HIEC
0.31 ± 0.09
0.30 ± 1.0

I

“ Glucose levels in mg/dl; group mean (n=6) ± standard error of the m ean (SEM).
GIR; glucose infusion rate during stable euglycemic period in ml/min
* Significant difference between lean and obese, p<0.05.

Baseline insulin, combining both the HIEC and LNA-HIEC studies,
was higher in the obese a n im a ls (p=0.0228; Table 4). However, the
difference in baseline (Pre-Clamp) insulin levels between the lean and obese
anim als in the HIEC study did not reach significance (Table 4), and the PreClamp difference in lean vs. obese insulin for the LNA-HIEC study
approached significance (p=0.053). Baseline insulin levels did not differ
between the HIEC and LNA-HIEC studies. The increase in insulin
observed during the stable hyperinsulinémie euglycemic period (Table 4;
Stable-Clamp) was significant, for both weight groups and both studies
(p<0.05).
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Table 4: Insulin^ levels during the EŒEC and LNA-HIEC studies.

P re -C lam p
S tab le-C lam p
Pre-Clamp*»
S tab le-C lam p
J ^ C L tfC t

L eant
Lean
Obese
Obese

A X 1 .C C U X O

m tm
WÊÊÊ
5.8
31.9
24.9
48.6

^

±
±
±
±

1.02
6.80#
8.55
15.7#

O M X X X U C L L \X C X X V X

3.7
39.3
16.72
50.6
L X IC

A iX C d ll

±
±
±
±

0.82*
15.0#
3.89
11.6#

\K J J U J ,r ± /,

Pre-Clamp period for th e LNA-HIEC study was post LNA administration.
* S ig n ific a n tly different &om Pre-ciamp insulin value of the obese a n im a ls i n same study
(LNA-HIEC). p=0.053.
^ Difference &om Pre-ciamp insulin value is significant (within the same weight group and
study), p<0.05.
t Significant difference in Lean Pre-ciamp insulin compared to obese Preciamp in s u lin , for
both studies combined, p<0.05.

Mean a rte ria l pressure during the HIEC was not different from th at
of the LNA-HIEC studies, in either the lean or obese dogs (Figure 11,
p=0.0857). Hyperinsulinemia did not significantly alter MAP in either
weight group in th e HIEC (Pre-HIEC vs. Post-HIEC) or LNA-HIEC studies
(LNA-Pre-HIEC vs. LNA-Post-HIEC). However, in the LNA-HIEC study,
the lean animals showed a trend toward reduction in MAP during
hyperinsulinemia, while the obese dogs tended to increase MAP (p=0.03
unadjusted for m ultiple comparisons) when the HIEC was performed after
NOS inhibition.
Analysis of th e data collected during the HIEC and LNA-HIEC
studies revealed th a t heart rate (Figure 12) was affected by weight group
and NOS inhibition, but was not affected by hyperinsulinemia. The average
difference in HR between the HIEC and LNA-HIEC studies w as greater in
the lean animals (38 BPM) compared to the obese (27 BPM), p=0.0004.
Also, the difference in heart rate between the lean and obese a n im a ls was
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Data are groups means ± SEM obtained during a stable 20 min baseline period before the
HIEC (Pre-HIEC or LNA-Pre-HIEC) and during the 20 min stable euglycemic period (PostHIEC or Post-LNA-HIEC).

Figure 11: MAP response to hyperinsulinemia alone (HIEC) or d uring NOS
inhibition (LNA-HIEC).
significantly influenced by whether it was m easured during the H IEC study
(lean-obese diflerence=27 BPM) or during the LNA- HIEC study (difference
between lean and obese=36 BPM), p=0.0169. D uring the HIEC study, the
difference in heart rate between the lean and obese weight groups w as not
significant. However, in the LNA-HIEC study, HR was significantly higher
in the obese (p=0.0049; Figure 12) during both the LNA-Pre-HIEC (p=0.01)
and the LNA-Post-HIEC (p=0.04) periods. Although, the HR differed

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

63

between the lean and obese during LNA-HTEC study, this difference was
evident prior to LNA adm inistration (p=0.0444; Figure 13), and heart rate
was not affected by the HIEC when performed alone or concurrent with
NOS inhibition.

160

HIEC

I Lean

149
138
s
0.
£.
o
a
cc
a
o
X

, O bese

127
116
105
94
83
72
61
50
160
149

s
0.
m
o
a
OC
a
«
X

138
127
116
105
94
83
72
61
50

Pre-HIEC
I Lean
. O bese

Post-HIEC

LNA-HIEC

L N A -P re -H IE C

LNA-Post-HIEC

* Significantly difierent from lean animals during the same study period, p<0.01.
D ata are group m eans ± SEM during a stable 20 m in baseline period before the HIEC (PreHIEC or LNA-Pre-HIEC) and during the 20 min stable euglycemic period (Post-HIEC or
LNA-Post-HIEC).

Figure 12: H eart rate response to hyperinsulinem ia alone (HIEC) or during
NOS inhibition (LNA-HIEC).
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Figure 13: H eart Rate response to LNA adm inistration during the LNAHIEC study
The difference in hind limb FVR between the HIEC and LNA-HIEC
studies was influenced by weight group (DNX, p=0.055; intact, p=0.0419
m ain effect of weight group) and NOS inhibitory statu s (DNX, p=0.052;
intact, p=0.017 for m ain effect of LNA treatment). However, there was no
overall difference in FVR response to acute hyperinsulinemia between the
intact and DNX limbs in either study, for either weight group. Although the
obese animals had lower FVR compared to the lean dogs during both
studies, the difference in FVR between the lean and obese only reached
significance in the LNA-HIEC study (p=0.046; Figure 14). During the LNAHIEC study, FVR was slightly higher th an that observed during th e HIEC
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study. However, only in the denervated limb of the obese a n im a ls did the
difference in FVR between the HIEC and the LNA-HIEC studies reach
significance (p=0.0064; Figure 15).
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“••• Significant difference in hind limb FVR between lean and obese during the LNA-HIEC
study, p<0.05.
Data are groups means ± SEM obtained during a stable 20 m in baseline period before the
HIEC (Pre-HIEC or LNA-Pre-HIEC) and during th e 20 min stable euglycemic period. (PostHIEC or Post-LNA-HIEC).

Figure 14: Femoral vascular response to hyperinsulinem ia alone (HIEC) or
during NOS inhibition (LNA-HIEC).
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Figure 15: Difference in denervated limb FVR of the obese dogs during the
HIEC and LNA-HIEC studies.
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CHAPTER 5: D ISCU SSIO N
The resu lts of these studies suggest that, contrary to our original
hypothesis, FVR increases immediately w ith weight gain. However, w ith
continued w eight gain, vascular resistance returns to baseline levels and
m ay drop below baseline levels. This vascular response may be influenced
by sympathetic activity, since the reduction in FVR observed with continued
weight gain occurred more rapidly in the denervated hind limb.
Additionally, these studies identify a difference in cardiovascular response
to LNA adm inistration (NOS inhibition) between lean and obese dogs. This
response is suggestive of a reduction in NOS activity in the obese. Finally,
our data suggest th at nitric oxide activity mediates insulin sensitivity.
As has previously been reported in dogs (Rocchini et al., 1987; T ruett
et al., 1996), overfeeding of a high-fat diet caused significant weight gain in
our animals. Consistent w ith our previous studies in which DEXA analysis
was employed (Truett et al., 1996), this weight gain w as associated
prim arily w ith an increase in fat deposition, although increased bone
m ineral content (BMC) was identified. However, it is unlikely th at the
m arked change in BMC is the result of weight-induced bone remodeling, but
rath e r was a limitation/artifact of the DEXA m easuring technique. Similar
artifacts have been reported when m easuring BMC in hum ans, and are
likely the result of beam hardening a t extremes of tissue thickness and
composition (Tothill and Pye, 1994; Tothill and Avanell, 1994; Jebb et al.,
1993).
67
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Study 1: Time course for the development of vascular resistance
changes and insulin resistance with obesity.
Although we observed a significant time effect of overfeeding on MAP
(measured weekly while on the treadmill; Figure 2), only in week 7 did the
increase differ significantly firom baseline. This elevation in MAP w as
shghtly delayed in onset compared to our previous work (Truett et al.,
1996), and may have been influenced by the presence of the Ls-Le
ganglionectomy or exercise.
In 1991, Galt and Cronenwett reported a reduction in the MAP of
anesthetized dogs in which unilateral lumbar sympathectomy procedures
had been performed. However, an earher report by this same group did not
identify significant reduction in MAP with ganglionectomy (Cronenwett and
Lindenauer, 1977). In neither case were the animals followed chronically
in the conscious state to determine whether the change in MAP was
persistent. Another chronic study using conscious dogs did not report MAP
m easurements (Lee et al., 1971). Thus, data in the literature is unclear,
and it is possible th a t the unilateral paravertebral ganglionectomy in our
study may have delayed the elevation of MAP with weight gain.
Another factor which m ay have influenced the development of
hypertension in these animals (though an unlikely factor) was the weekly
exercise regimen (walking <1.6 km/hr [0.44 m/s]; 30 min/week). Moderate
exercise is known to reduce arterial pressure in hum ans (Jennings et al.,
1984 and 1986; KingweU et al., 1993; Pescatello et al., 1991). Most hum an
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studies describe moderate exercise paradigms as 30-45 min of exercise three
tim es per week, while m aintaining approximately 60% Workmax. (Jennings
et al-,1984 and 1986; KingweU an d Jennings, 1993) or 70-80% Vozmax.
(Rogers et al., 1996). In the study by Rogers et al. (1996), low-intensity
exercise training (40-50% Vozm ax, 3 times/wk) was reported to be a more
effective stimulus in reducing resting arterial pressure and blood pressure
responses to stress th a n was m oderate-intensity exercise (70-80%

V ozm ax)

in

borderline hypertensive humans. Although this study reported a pressurereducing benefit of exercise in hum ans, the exercise level, even in the lowintensity paradigm, was much more intense th a n th a t used in our weekly
canine regimen. Thus, based upon hum an work, it is unlikely th a t the level
of exercise provided by the weekly 30 min walking regimen w as responsible
for the delay in onset of elevated MAP in our dogs.
By comparison, O’Leary et al., (1997) used 8 km/hr w ith a 15% grade
as a moderate exercise regimen in dogs. Mild exercise was described as 3.2
km/h a t 0% grade in th a t study, while 4 km/h w ith a 13% grade, was used
as a “mild” exercise regimen in dogs in a study examining systemic and
regional blood flow a t various exercise intensities (Pagny et al., 1986). The
dogs in our studies walked slowly on a treadmill during the weekly studies
a t a speed less th an <1.6 km/h, w ith zero grade. According to h e a rt rate and
oxygen consumption d ata previously observed in response to treadm ill
exercise in dogs (CerreteUi et al., 1964), the workload of our dogs, even a t
the highest average HR (week 7 w alking HR =129 ± 8.4 BPM) corresponds
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to less th an 25% V0 2 max. if assessed using the graph presented in the
CerreteUi study. Thus, the exercise level of our dogs was considerably less
th an th a t used in mild or low intensity exercise regimens in other canine
studies, and one would not expect the exercise program to have influenced
chronic MAP m easurem ents.
Our study examining changes in vascular resistance w ith weight gain
appear to indicate th a t femoral artery vascular resistance increases
immediately foUowing overfeeding/weight gain, and a reduction in FVR
ensues w ith continued weight increase. These vascular changes may be
influenced by autonomic nervous system input, as the reduction in FVR
occurred earher in the limb in which a lumbar sym pathetic ganghonectomy
was present. Systemic vascular resistance has been reported to be higher
(Rocchini et al., 1987) and total peripheral resistance (TPR) reported to be
lower th an norm al in obese dogs (MizeUe et al., 1994; Hall et al., 1995).
MizeUe et al. reported an initial reduction in TPR foUowed by a trend
toward, but not reaching, normal levels by week 4 of high-fat feeding. O ur
results, however, suggest th at although a normal or reduced vascular
resistance may be present in the obese dog, the initial stages of weight gain
are associated w ith higher th an norm al FVR. As h teratu re regarding th is
subject conflicts, further work in th is area is w arranted. Additionally,
sympathetic activity may influence the vascular changes occurring during
the initial period of weight gain, since the reduction in FVR to baseline
levels as weight gain continued was prolonged in the intact limb. This
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suggests th a t sympathetic activity to the limb is instrum ental in
m aintaining vascular resistance at a level higher th an th a t in vessels
without sym pathetic input. This too, w arrants further study.
In examination of the relationship of insulin and w eight gain in these
studies, we observed increasing in s u lin concentrations (as a reflection of
increasing insulin resistance) w ith weight gain. However, in s u lin did not
appear to correlate with arterial pressure or vascular resistance. This is
consistent w ith the work of John Hall and his colleagues (1990; 1995), who
could not identify an effect of chronic insulin infusion to increase arterial
pressure in lean or obese dogs. Although a correlation betw een in s u lin and
the cardiovascular param eters (HR, MAP, or FVR) was not evident, the
significant increase in insulin preceded the return of FVR by 1 week in the
DNX limb, b ut by 3 weeks in the intact leg. This suggests th a t the
increasing insulin concentration may work toward reductions in FVR and
arterial pressure with weight gain were there not concurrent increased SNS
activity in the obese. Previous findings th a t insulin infusion stim ulates
vasodilation (For review see Baron, 1994) and a reduction in arterial
pressure (Hall et al., 1995) support this theory. Our findings suggest th a t
autonomic activity in the intact hmb influences FVR during weight gain,
and increased insulin levels may help prevent continued elevation in FVR
in vessels th a t remain sensitive to its effects. Thus, sym pathetic activity
may be an initiating factor predisposing to the development of hypertension
associated w ith weight gain, and interaction with insulin may be important.
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However, we did not observe a difference in response to acute
hyperinsulinemia between lean and obese dogs in the HIEC portions of our
studies, nor were there differences in the response to hyperinsulinemia in
the DNX and intact limbs.
A recent study identified renal sympathetic activity as a prim ary
cause of hypertension in obesity (Kassab et al., 1994). In th a t study,
bilateral renal denervation greatly attenuated the development of
hypertension with overfeeding. Thus, although sympathetic ren al
mechanisms appear to be a prim ary factor involved in the development of
obesity-related hypertension (Kassab et al., 1994), our study suggests th a t
peripheral vascular effects of increased sympathetic activity m ay also be
im portant in initiating the development of hypertension, prior to
measurable changes in arterial pressure. These vascular changes may play
a pivotal role in the series of events leading to hypertension in the obese.
They are not likely, however, to be working alone, and w arrant further
study.
Study 2: Cardiovascular parameters following NOS inhibition with
LNA.
This study of canine cardiovascular function and stabilization
following nitric oxide inhibition indicates th a t MAP, heart rate (HR) and
femoral vascular resistance (FVR) are altered by adm inistration of L-nitroarginine. Also, the data suggest th a t the cardiovascular response to NOS
inhibition differs between lean and obese dogs. Finally, once acclimated to
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NOS inhibition, cardiovascular param eters rem ain stable for the time
period required to perform the hyperinsulinémie euglycemic clamp
procedures described in our prim ary experiments.
In this experiment, acute nitric oxide synthase in h ib itio n w ith LNA
sig n ific a n t l y increased MAP, which is consistent w ith previous fin d in g s by

Eisner et al., 1992. As in the E isner study, a s ig n ific a n t reduction in h eart
rate occurred following LNA treatm en t in our animals, b u t this response
was significantly reduced in the obese. In addition, the obese dogs had a
significantly lower FVR response to LNA. The obese a n i m a ls in both the
LNA-time course and the LNA-HIEC studies failed to show a significant
change in FVR following LNA adm inistration. However, a significant FVR
response to LNA was evident in the lean dogs, suggesting greater NOS
activity compared to the obese. This observation is consistent with the
previous work in essential hypertensives, who exhibit reduced vascular
relaxation (Panza et al., 1993a, b). The reduction in vascular reactivity in
this population is thought to involve abnorm ahties of th e NOS pathway
(Panza et al., 1990 and 1993b). However, it is not due to reduced
availabihty of the n atu ral substrate for NO synthesis (Panza et al., 1993a),
and is not isolated to a specific defect of endothehal cell muscarinic
receptors (Panza et al., 1994) or a single signal transduction pathway
(Panza et al., 1995). Thus, although data are growing to describe the
mechanisms through which reduced vascular response to NOS inhibition
occurs in a population w ith physiologic changes sim ilar to th a t of the obese
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(essential hypertensives), the pathw ays remain obscure. The reduced
vascular response to NOS inhibition in the obese could reflect a defect in
NO synthesis, release or diffusion of NO to vascular smooth muscle.
In addition to th e finding th a t after initial changes in MAP, HR and
FVR cardiovascular param eters stabilize following LNA adm inistration,
this study suggests th a t obesity is a disorder of altered activity of the nitric
oxide system. The obese anim als of this study exhibited a reduced
cardiovascular response to NOS inhibition. Also, the vascular response to
NOS inhibition may be influenced by sympathetic nervous system activity,
since the denervated an d intact limb FVR response to LNA adm inistration
differed in the lean dogs. Additionally, since the FVR response to NOS
inhibition differed in lean and obese dogs, this could be a pathway
mediating the development of hypertension with weight gain.
Studies 3 and 4: The HIEC, alone and following NOS inhibition.
In these studies examining the interaction of NOS, in s u lin and
sympathetic activity, baseline insulin levels of the obese animals were
greater th a n the lean. This suggests reduced in s u lin sensitivity in the over
weight dogs, reflected as higher insulin levels. The finding of higher glucose
infusion rates (GIR) during hyperinsulinémie euglycemia in the lean
a n im a ls also supports a difference in insulin sensitivity between the weight

groups (i.e. the lean are more sensitive to insulin-stimulated glucose
disposal, thus require higher exogenous glucose infusion to m aintain
euglycemia). These observations are consistent w ith previous f in d i n g s of
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hyperinsulinem ia and/or reduced response to a glucose tolerance test in the
obese, reflecting resistance to insulin stim ulated glucose disposal (Rocchini
et al., 1987, 1989 and 1996; T ru ett et al., 1996).
When hyperinsulinémie euglycemia was performed concurrent w ith
NOS inhibition (LNA-HIEC study), no difference in GIR betw een the lean
and obese anim als was observed. Thus, NOS activity appears to influence
insulin sensitivity in the canine. This fin d in g contradicts those of Swislocki
et al. (1995), who report s im ila r glucose tolerance in response to oral glucose
tolerance tests in controls and ra ts a d m in is te r e d L-NAME i n th eir drinking
w ater. However, our data coincide with a study by Petrie et al. (1996), who
report a positive relationship between basal vascular NO production and
insulin sensitivity in humans. In th a t study, individuals who were
relatively insensitive to insulin-mediated glucose uptake using the clamp
m ethod also exhibited decreases in basal endothehal NO production.
Although glucose infusion rate within each weight group did not
differ between the HIEC and LNA-HIEC studies, the lean anim als tended to
require a lower infusion rate of glucose when the clamp procedure was
performed following LNA administration. This suggests th a t NOS
inhibition may have a greater effect on i n s u l i n sensitivity in norm al
compared to obese dogs. Two mechanism through which a reduction in
insulin sensitivity may have occurred in the lean versus the obese dogs in
our studies are:
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1) A greater increase in vascular resistance following LNA in the
lean animals caused a greater reduction in blood flow in this
group. This reduction in flow decreased insulin dehvery to
tissues, thereby reducing insulin stim ulated glucose disposal and
insulin sensitivity of the lean anim als.
2) If insulin's effect to reduce vascular tone and stim ulate glucose
uptake is m ediated partly through nitric oxide activity (Chen and
Messina, 1996; Baron, 1996), reduced NOS activity in the obese
a n im a ls would cause a baseline in s u lin resistance in this weight

group. The lean animals, having greater baseline NOS activity
would be more sensitive to insulin stim ulation. If NOS was
inhibited in both lean and obese a n im a ls , the change in insulin
sensitivity between studies w ith and w ithout NOS inhibition
should be larger in the lean animals (since they should have
greater baseline NOS activity). Thus, the influence of blocking
nitric oxide on insulin’s abihty to stim ulate glucose disposal
should be more severely affected in the lean a n i m a ls
In support of mechanism num ber 1, insulin resistan t subjects [obese
in our study] are known to have a reduced vascular response to NO blockade
(Panza et al., 1993a and b [in essential hypertensives]; Petrie et al., 1996).
Thus, if vascular NOS activity is greater in the lean insulin sensitive dogs,
there m ay have been a greater effect of NOS inhibition to reduce tissue
perfusion in this group. The larger increase in FVR (lower flow) of th e lean
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dogs may have resulted in a reduction in insulin delivery, and a tendency
toward reduced insulin sensitivity during the LNA-HIEC study. Skeletal
muscle blood flow is known to modulate insulin-mediated glucose uptake
(Baron et al., 1994). Thus, differences in tissue perfusion could have
affected insulin sensitivity (as reflected by GIR) in these studies. In the
obese dogs, w ith reduced baseline NOS activity, the vasculature may have
been less affected by NOS inhibition. Thus, insulin delivery (resultant firom
changes in blood flow/FVR) may not have been as greatly altered in the
obese dogs during h y p e r in s u lin e m ia in LNA-HIEC study. Thus, in s u lin
sensitivity would not appear to d iffe r between the HIEC and LNA-HIEC
studies in the obese (as observed in our dogs). In the lean anim als of the
LNA-HIEC study, the effects of LNA to increase vascular resistance (reduce
flow) may have been greater th a n in the obese. This lower flow in the lean
a n im a ls of the LNA Study may have resulted in reduced glucose disposal

(seen as increased glucose infusion rate of the lean, compared to the HIEC
study alone). Thus, the difference in glucose infusion rates between lean
and obese dogs of the HIEC study would no longer be evident in the LNAHIEC study. The findings of Baron and his colleagues (1995), suggest th a t
reduced skeletal muscle perfusion contributes to insulin resistance induced
by L-NMMA in rats. In addition, the work of Bergman and his colleagues
suggests th a t delayed in s u lin delivery to tissues an im portant factor in the
insulin pathw ay responsible for the insulin resistant state (Yang et al.,
1989; Ader and Bergman, 1994), and is thus somewhat flow dependent.
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Thus, the insulin sensitivity results of our HIEC an d LNA-HIEC studies
could possibly reflect differing tissue perfusion.
The finding of reduced insulin sensitivity m ainly in the lean dogs
during the LNA-HIEC study also supports the second hypothesized
mechanism of NOS-insulin interaction (NOS-mediated insulin activity
mediates insulin sensitivity/glucose uptake). There is a large body of
evidence supporting the fact th at insulin-m ediated vasodilation is nitric
oxide dependent (Steinberg et al., 1994; Scherrer, et al., 1994) an d the
degree of vasodilation is proportional to insulin sensitivity (For review see
Baron, 1996). In obese hum ans with and without NIDDM, a recent study
found a 40-50% reduction in endothelium-dependent vasodilation under
basal conditions, as well as a marked im pairm ent of insulin’s physiologic
abihty to enhance this response (Steinberg et al., 1996). The lean anim als
of our study exhibited a greater increase in FVR w ith LNA adm inistration
th a n observed in the obese (Study 2 of these experiments; the LNAcardiovascular stabihzation study). This suggests higher NOS activity in
the lean versus obese dogs in the basal state. Thus, in sulin (if m ediated
through NO activation) should have caused a greater effect on glucose
disposal in th e lean animals, as observed in the HIEC study. Also, if basal
NO activity is increased in the lean, baseline insulin sensitivity should also
be higher th a n in the obese. This w as the case in the lean anim als of our
studies, who had increased insulin sensitivity compared to the obese dogs of
our studies (based upon higher basal insulin levels and increased glucose
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infusion rates required to m aintain euglycemia during hyperinsulinemia).
These d ata suggest th a t insulin action may be m ediated by nitric oxide.
Also, NOS inhibition appears to have a greater effect on insulin sensitivity
in lean versus obese dogs, possibly due to greater nitric oxide activity in
lean individuals.
In the HIEC and LNA-HIEC studies, MAP was not significantly
affected by acute hyperinsulinemia, in either th e lean or obese dogs. This
finding is consistent w ith data of H all et al., 1995, who did not find
significant elevations in MAP with chronic insulin infusion in normal or
obese dogs. Interestingly however, the change in MAP observed in response
to hyperinsulinemia when NOS was concurrently inhibited (LNA-HIEC
study) varied shghtly between the lean and obese. In this study,
hyperinsulinemia tended to reduce MAP in the lean animals, whereas MAP
in the obese animals was shghtly increased. Although these differences
were not significant in our small group of animals, further study is
w arranted.
Although MAP increased shghtly in the obese and shghtly decreased
in the lean foUowing hyperinsulinemia during th e LNA-HIEC study, neither
the femoral vascular resistance or HR was significantly influenced by
hyperinsulinemia alone (HIEC) or concurrent w ith NOS inhibition (LNAHIEC). However, in the lean animals a shght reduction in FVR was
observed when insulin was infused foUowing LNA adm inistration. This was
not observed in the obese. Also, the obese dogs exhibited a shght increase in
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HR during insulin infusion in th e LNA study. This increase in HR suggests
a n increase in cardiac output (CO) occurred with insulin infusion, as
previously reported (for review see Baron, 1994). In the presence of an
inappropriate vascular response in the obese dogs however, this increase in
CO may have led to the increase in obese MAP. In the lean group, who had
a more appropriate reduction in FVR (though not significant) in response to
a n increase in CO, MAP rem ained unchanged. This hypothesis cannot be
proven firom our d ata however, since cardiac output was not m easured in
our studies.
Since increases in MAP reflect changes in systemic vascular
resistance, cardiac output, or blood volume/renal mechanisms (Guyton,
1991), one cannot fail to mention other mechanisms through which the
shght increase in MAP observed in the obese during NOS inhibition and
insulin infusion may have developed. Increases in vascular resistance may
have occurred in unmeasured portions of the circulatory system (other th an
th e femoral arteries) or renal fluid retention may have precipitated
increases in plasm a volume and cardiac output. Alternatively, a direct
change in cardiac inotropic function may have taken place, increasing
stroke volume and cardiac output (CO =stroke volume . HR) and
precipitating the pressure elevation observed in the obese dogs during the
LNA-HIEC study. However, neither renal function nor cardiac output were
m easured in these experiments.
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Although the data do not prove th a t cardiac output increased with
insulin infusion, and the cardiovascular changes discussed above did not
reach significance, basehne d ata collected during these studies support the
hypothesis th a t abnormal vascular responses were present in the obese
anim als. P rior to m anipulation w ith insu lin , the HR of the obese dogs in

the LNA-EŒEC study was greater th an th a t of the lean anim als However,
although FVR is lower in the obese group, the obese dog MAP is shghtly
higher th an th e lean. Thus, prior to insulin adm inistration, the peripheral
vascular response to the increased heart rate in the obese anim als was not
adequate to compensate for the assumed higher cardiac output (CO=stroke
volume . HR) of the obese animals. Thus, infusion of insulin may have
further increased cardiac output, and with inadequate peripheral vascular
response in the obese, MAP increased. As mentioned above, CO=SV.HR,
and changes in muscular efficiency of the h eart can occur which may negate
a rise in CO w ith a concurrent rise in HR (Guyton, 1991). Thus,
inappropriate vascular response to an increase in CO induced by insulin
m ay have resulted in the increase in MAP observed in the obese group.
Since we did not measure cardiac output, we cannot prove th a t the higher
baseline HR of the obese was associated w ith increased CO, nor th a t insulin
increased CO during hyperinsulinemia.
Though an unlikely mechanism, MAP m ay have increased during
acute hyperinsulinem ia and concurrent NOS inhibition via renal
mechanisms. Nitric oxide inhibition has been shown to increase renal
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vascular resistance and reduce renal blood/plasma flow in dogs (Eisner et
al., 1992; Majid et al., 1993), reducing sodium excretion (Majid et al., 1993).
Additionally, nitric oxide-induced changes in the renin-angiotensin system
are reported, b u t are not as clear (Eisner e t al., 1992; Salazar et al., 1992;
Schnackenberg et al., 1997; Sigmon et al., 1992). LNA-induced changes in
renal function may have led to reduced sodium and w ater excretion in the
anim als of the LNA-HIEC study. Additional exogenous infusion of insulin
and glucose during the clamp procedure m ay have compounded fluid
changes occurring with LNA adm inistration. Since insulin is known to have
anti-natriuretic effects (DeFronzo, 1976, Rocchini et al 1989b), the obese are
reported to have a reduced natriuretic response to volume expansion (West
e t al., 1992), and insulin resistant hypertensive dogs m ay have increased
renal sensitivity to NOS inhibition (M artinez et al., 1993), performing the
clamp procedure with concurrent NOS inhibition may have changed renal
fluid handling enough to increase MAP (via volume expansion) in the obese
but not the lean dogs. Total body w ater and renal function were not
m easured in our studies, so these hypotheses are only speculation. Renal
regulation of arterial pressure is a more chronic method of pressure
regulation. Thus, significant volume expansion (with associated increases
in cardiac output and MAP) would be unlikely in such a short protocol
(approximately 2hr). Additionally, average quantity of fluid (insulin and
glucose infusions) administered to the obese dogs in the LNA-HIEC study
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was approximately 60 ml, which would be unlikely to cause significant,
volume expansion.
Thus these studies suggest th at interaction between in sulin and
nitric oxide may influence cardiovascular responses to weight gain. The
nitric oxide system is im portant for the lean and obese response to insulin,
and m ay be an im portant m echanism influencing insulin sensitivity.
Although the results did not reach significance, differences in the insulinnitric oxide relationship in the vasculature of the obese may occur, with a
trend toward elevations in arterial pressure during acute hyperinsulinemia.
However, the mechanism through which arterial pressure increases in the
obese when insulin is infused during NOS inhibition remains obscure.
The small number of anim als used in these studies, and the large
variation in response may have overshadowed the abihty to identify small
significant differences (especially since unadjusted p-values suggest a trend
toward increased MAP and HR in the obese). This area deserves further
study, since this alteration m ay be important in the arterial pressure
response to weight gain as MAP tended to increase in the obese but
decrease in the lean.
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CHAPTERS: CONCLUSIONS
The studies described herein suggest th a t in the initial stages of
overfeeding, there is increase in FVR, which then decreases to normal
levels. The changes in FVR appear to be influenced by sympathetic activity,
as the retu rn to baseline FVR was delayed in the limb retaining normal
sympathetic innervation. Interaction of in s u lin w ith the vascular responses
to weight gain does not appear significant, since correlation was not evident
between insulin levels and vascular resistance.
The prim ary studies also provided interesting data about the
NOS/insulin/SNS relationship. Lean and obese dogs respond differently to
nitric oxide synthase inhibition: the obese exhibited a reduced
cardiovascular response to LNA adm inistration (Study 2). As we
hypothesized, SNS activity may be an important mediator (inhibitor) of NO
activity, since the denervated limbs of the lean dogs showed a greater
increase in FVR following NOS inhibition. In addition, this SNS/NO
interaction may be abnormal in the obese, since the response of the DNX
limb of the obese dogs was lower th a n in the lean. We speculate th a t higher
sympathetic activity in the obese may reduce peripheral NOS activity in
this population, and reduce NOS-mediated vascular relaxation. F urther
examination of the nitric oxide/SNS interaction is w arranted in the search
for the mechanisms involved in the development of hypertension in the
obese.
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Contrary to our hypothesis th a t NOS-mediated vascular response to
insulin is abnorm al in the obese, these studies did not identify a significant
difference in cardiovascular response to hyperinsulinémie euglycemia
between lean and obese dogs, w hen performed alone or in concert with nitric
oxide inhibition. However, the trend toward increasing MAP w ith insulin
infusion and concurrent NOS inhibition in the obese suggests th a t changes
in the insulin-NO relationship may occur in the obese, predisposing to
elevated arte ria l pressure. Thus, further study, using a larger sample size,
is w arranted to clarify changes in nitric oxide and insulin responses of the
obese.
Another interesting finding of these studies is th a t NO activity
influences insulin sensitivity in lean animals, w ith NOS inhibition resulting
in a more ‘resistan t’ state. This ‘resistance’ may involve a greater effect of
NOS inhibition to reduce blood flow in the lean thereby altering insulin
delivery to tissues, or may occur via reduced NOS-mediated in sulin
stim ulated glucose disposal. Increases in SNS activity reported to occur in
the obese may be a mechanism mediating this reduction in NOS activity,
and thus indirectly influence insulin sensitivity.
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A PPEN D IX B: ABBREVIATIONS
ACH

acetylcholine

BMC

bone mineral content obtained using DEXA

BPM

beats per minute

cGMP

guanosine 3’, 5’-cycbc monophosphate

CNS

central nervous system

DEXA

dual emission x-ray absorptiometry

DNX

SNS denervated limb (La-Le paravertebral gangbonectomy)

FBF

femoral artery blood flow

FVR

femoral vascular resistance calculated using FVR = MAP/FBF

HR

h ea rt rate (BPM)

Intact

limb w ith sympathetic activity intact (right hind limb)

lU

international units

LBM

lean body mass obtained using DEXA

LBNP

lower body negative pressure

LNA or
L-NAME

NG-nitro-L-arginine-methyl ester

LNMMA

L-N*^-monomethyl-arginine

LNNA

N*^-nitro-L-argi nine

MAP

m ean arterial pressure (mmHg)

NE

norepinephrine

NIDDM

non-insulin dependent diabetes mellitus
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NO

nitric oxide

NOS

nitric oxide synthase

NTS

nucleus tractus solitarius

SEM

standard error of the group mean

SHE

spontaneously hypertensive ra t

SNS

sympathetic nervous system
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